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ABSTRACT 
 Sepsis is an immunological condition defined by a pathogen inducing the 
Systemic Inflammatory Response Syndrome (SIRS), which itself is a clinical diagnosis 
involving temperature, heart rate, respiration, and white blood cell (WBC) count.  
Our lab uses Cecal Ligation and Puncture (CLP) to induce polymicrobial sepsis in 
mice, with a mortality rate of 50 percent. Previous research in our lab has demonstrated 
that the plasma levels of IL-6 collected six hours after the start of sepsis can be used to 
predict which mice will live (Live-P) and which mice will die (Die-P) during the acute 
phase (<5 days post CLP). This predictive tool enables stratification of mice prior to 
mortality to determine immunological differences between groups. With this approach it 
was found that both Live-P and Die-P mice have equivalent bacterial burden and 
phagocyte recruitment within 6 hours of CLP. Yet by 24 hours, Die-P mice have 
increased bacterial burden while recruiting more phagocytes than Live-P. This suggested 
a phagocytic impairment.  
This study reproduced the aforementioned findings and subsequently determined 
that Die-P peritoneal phagocytes kill fewer bacteria than Live-P. This bactericidal deficit 
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was associated with multiple cellular defects. The reduced cellular function 
included: decreased phagocytosis, decreased phagosomal acidification, and decreased 
generation of reactive oxygen species (ROS). All of these are integral components of the 
bacterial killing process. Furthermore, it was found that this deficit was due to cellular 
suppression and not to cellular exhaustion. The study of phagocytic function was then 
extended to the bone marrow, a source of phagocytes, and to the peripheral blood. Die-P 
bone marrow phagocytes showed increased phagocytic activity despite a similar capacity 
to respond to bacteria as Live-P. Additionally, Die-P bone marrow phagocytes were 
found to express higher levels CD11b, a marker of activation. Conversely, Die-P 
peripheral blood phagocytes expressed higher levels of activation markers while 
exhibiting decreased phagocytic functions. 
This study then recapitulated the phagocytic dysfunction of septic cells with naïve 
healthy cells. A surge in pro and anti-inflammatory mediators is a hallmark of sepsis, 
with Die-P mice producing a significantly larger surge. Naïve phagocytes were incubated 
with plasma or peritoneal fluid from Live-P and Die-P mice and it was found that Die-P 
fluids significantly compromised the phagocytic activity of naïve phagocytes. 
These studies collectively suggest that mortality from CLP induced sepsis is due to 
failure to kill bacteria and that differential production of inflammatory mediators 
contributes to the differences in phagocytic function. 
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1 CHAPTER ONE: GENERAL INTRODUCTION 
Introduction 
1.  
Sepsis is the leading cause of morbidity and mortality in hospital intensive care units. It is 
the 10th leading cause of death in the united states [1]. It costs society an estimated 24 
billion dollars annually and this cost is increasing [2]. The overall prevalence and cost of 
sepsis has doubled from 2000-2008 [3, 4] and this rate is projected to increase as the 
increased use of immunosuppressive therapies and an aging population takes its toll. 
Since the advent of antibiotics in the middle of the last century, little progress has been 
made in reducing sepsis mortality [5, 6], which ranges from ~25-60%, depending on 
severity [7]. If sepsis outcome is considered beyond the standard 28 day window, 
mortality increases with nearly 80% mortality within 5 years. Sepsis is classically defined 
as a systemic dysregulation of the immune system.  Clinically, sepsis is defined as the co-
presentation of infection, or suspicion of one,  and Systemic Inflammatory Response 
Syndrome (SIRS), where SIRS is a diagnosis involving temperature ( >38.3C or < 36C), 
heart rate (>90 beats/min), respiration (>20breaths/min or PaCO2 <32mmHg, and white 
blood cell (WBC) count (>12*109/L or <4 *109/L) [8]. As disease severity progresses, 
additional classifications are made. Severe sepsis, which compounds sepsis with organ 
dysfunction, and septic shock, which is sepsis in addition to hypotension despite adequate 
fluid resuscitation are more severe forms of sepsis. However, these classifications do 
little to direct the course of treatment. 
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Sepsis Pathophysiology  
 
Sepsis is thought to originate from trauma or infection that results in an aberrant 
inflammatory response. Early work on this concept was performed with the endotoxin 
lipopolysaccharide (LPS), a cell wall component of gram negative bacteria [9]. LPS, a 
Pathogen Associated Molecular Pattern (PAMP) binds to TLR-4, a Pattern Recognition 
Receptor (PRR) that is expressed on mammalian cells and most notably on macrophages. 
TLR-4 ligation results in the secretion of pro-inflammatory cytokines and chemokines 
that initiate an inflammatory response and recruit additional immune cells such as 
neutrophils (PMNs) to eradicate the infection [10, 11]. However, too much PAMP/PRR 
signaling may be detrimental to the host.  
 
It was thought that the early stages of sepsis were the result of a powerful pro-
inflammatory response that led to systemic activation of the immune system and resulted 
in SIRS. During SIRS, hyper-activation of immune cells is thought to lead to increased 
organ damage. Neutrophil derived inflammatory mediators can damage the vascular 
endothelium, resulting in necrosis and apoptosis [12] and subsequent hemodynamic 
changes leading to tissue hypoxia [13, 14]. This is thought to lead to multiple organ 
failure in sepsis [15, 16] The SIRS phase is then followed by the Compensatory Anti-
inflammatory Response Syndrome (CARS) [17] that results in global 
immunosuppression and increased susceptibility to secondary infection [18, 19]. 
However, recent evidence suggests that in sepsis, SIRS and CARS occur simultaneously 
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[20, 21] and the magnitude of these concomitant responses predicts mortality [22, 23]. 
Although the overlap of SIRS and CARS fits within feed-forward immunological 
feedback loop models, it is likely that the traumatic or infectious insult is of sufficient 
magnitude so as to overwhelm the immunological control mechanisms responsible for a 
coordinated response. A prototypical pro-inflammatory immune response is such that an 
inflammatory trigger results in activation of pro-inflammatory signaling that propagates 
in a self-amplifying feed-forward manner (Fig 1.1A). This self-amplifying process would 
enable the quick mobilization of immunity. Once the pro-inflammatory drive crosses a 
signaling threshold [24], a negative feedback loop is triggered to prevent the dangers of 
unrestrained inflammation [25]. In the context of sepsis, the initial insult may be 
sufficiently large to trigger both responses simultaneously (Fig 1.1B), thus acting to blunt 
the immune response before it can eradicate the infection. This model may in part explain 
why immune-suppression develops in sepsis.  
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Figure 1-1 Immune Deregulation in Sepsis. A- Prototypical immune response. B- 
Uncoordinated immune response in sepsis. 
 
Sepsis Treatment 
 
Current treatment for sepsis includes antibiotic therapy, infectious source control, fluid 
resuscitation, and other procedures aimed at maintaining hemodynamic stability [26]. 
Although this approach has reduced 28-day mortality, it is not known for certain how this 
is achieved [27]. For every hour passed between the onset of hypotension to antibiotic 
administration, there was a 7.6% increase in in-hospital mortality [28], highlighting the 
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importance of bacterial clearance.  Despite this regimen, complications frequently 
develop such as acute respiratory failure, acute renal failure, shock, coagulopathy, and 
multiple organ failure [8, 29].  The idea that mortality derives from excessive 
inflammation led to therapies such as Anti-Tumor Necrosis Factor (TNF), and anti-
Interleukin-1 (IL-1). While these therapies showed promise in lab animals, they 
ultimately failed to improve outcome in humans [8]. 
 
Similarly, trials with recombinant activated protein C (APC), an inhibitor of coagulation; 
eritoran, a Toll-like Receptor 4 (TLR-4) blocker, and talactoferrin, an immune stimulant, 
either failed or were stopped due to worsened outcome [30]. It is likely that heterogeneity 
exists within and across the different classifications of sepsis and this complicates 
treatment. SIRS, sepsis, severe sepsis, and septic shock do not factor in variables such as 
the pathogen, comorbidities, or patient demographics. To address this, consideration of 
predisposing factors, the infection, the response, and organ failure (PIRO) of the host 
have been used to stratify patients by likelihood of mortality [31]. Further complicating 
sepsis therapy is that we still do not know exactly why patients die from sepsis, thus 
highlighting the need for more research into the mediators of mortality in sepsis. 
 
Animal Models of Sepsis  
An appropriate model is at the heart of studying sepsis. A TNF blockade improved 
survival in a murine model of LPS-induced endotoxemia sepsis, however, the same study 
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demonstrated that a blockade of TNF in a CLP model did not improve survival [32]. This 
stresses the importance of selecting a sepsis model with clinical relevance. 
 
There are three general categories of sepsis models: Endotoxin administration (i.e. LPS), 
exogenous bacterial administration, or host-barrier disruption models such as CLP which 
results in necrotizing tissue and the release of intestinal flora into the peritoneum. Each 
model has its advantages and disadvantages. Endotoxemia can be tightly controlled by 
the amount of toxin given, however it results in a rapid rise and decline in cytokine levels 
which differs from the sustained and more moderate levels seen in human sepsis. 
Exogenous bacteria tend not to colonize the host and thus resemble an endotoxemia 
model to some extent. The choice of bacteria will also affect the host response, as will the 
site of administration. CLP introduces layers of complexity such as multiple bacterial 
species, animal age, and animal strain variability [33, 34]. However, CLP is considered 
the gold standard for sepsis studies and for good reason; it shares many characteristics 
with human sepsis such as hemodynamic alterations and changes in body temperature 
[35, 36], improved response to antibiotic therapy [37], a massive parallel pro and anti-
inflammatory cytokine storm [38], and a clinical correlate in perforated and/or 
necrotizing bowels. Furthermore, the severity of CLP may be altered to investigate 
phenomenon associated with a particular severity of disease[36]. 
 
Our lab is interested in what mediates mortality in CLP induced sepsis, with care taken to 
be as clinically relevant as possible. Outbred mice are used, as they have been shown to 
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more closely model the heterogeneity prevalent in humans [39] and their course of 
disease [40]. Fluid resuscitation, broad spectrum antibiotics, and pain control are also 
provided in a manner similar to the clinic [41]. 
 
To determine what mediates mortality in CLP induced sepsis, it would be helpful to 
know in advance which animals will survive. Using an LD50 model of CLP, IL-6 was 
found to predict mortality with great sensitivity and specificity during the acute phase of 
sepsis [42]. This predictive tool allows more defined studies to delineate what goes 
wrong in sepsis, as well as providing a means for more targeted interventions and 
assessments of efficacy. Indeed, recent work in mice has shown that dexamethasone 
treatment fails to improve overall survival from CLP-induced sepsis, however, by 
stratifying mice into Live-predicted (Live-P) versus Die-predicted (Die-P) groups, a 
marked improvement in survival was found for mice that would have otherwise 
succumbed [43]. Stratification has also yielded interesting clues for the mechanisms of 
mortality. Six hours Post-CLP, the peritoneal cavity of both Live-P and Die-P mice 
contain similar numbers of neutrophils and macrophages (phagocytes), and bacterial 
CFUs.  
 
Yet by 24 hours post-CLP, Die-P mice have significantly more peritoneal phagocytes and 
CFUs [44]. These data suggests that there is a defect in the phagocytes of Die-P mice. 
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Phagocytes and Sepsis 
The phagocytes, primarily neutrophils (PMN) and macrophages/monocytes (Macs) are at 
the front lines of host defense and are essential for protecting the host from extracellular 
infection. The principal means by which they protect against microbial infection is via 
phagocytosis, a process in which they engulf and destroy the infectious agent [45]. 
Phagocytes possess several pathways by which they can recognize and ingest infectious 
agents. Antibodies or complement can opsonize microbes, thereby allowing phagocytosis 
via the Fc-Receptor (FcR) or complement receptor (CR) pathways, respectively. 
Similarly, phagocytes possess scavenger receptors (SR) that are capable of directly 
binding microbes in an opsonin independent manner. Although PMNs and Macs 
phagocytize to kill pathogens, they each have their own signature bactericidal processes. 
At the heart of PMN bactericidal processes is the NADPH Oxidase (NOX) complex and 
various granules. PMN granules are classified as Azurophilic, Specific, Tertiary, or 
Secretory. Azurophilic granules are filled with lysosomal proteases and are considered 
the bactericidal compartment mobilized by phagocytosis. Specific granules contain 
additional antimicrobial contents, tertiary granules contain enzymes for extravasation of 
PMN into tissues, and secretory granules contain multiple types of receptors (i.e. CD11b) 
which are brought to the surface upon activation [46].  
NOX is a transmembrane protein complex which catalyzes the reduction of oxygen to 
superoxide anions, the primary Reactive Oxygen Species (ROS) which gives rise to 
various other ROS [47]. NOX is located throughout the plasma membrane of PMNs 
which positions it to pump ROS into the extracellular environment, as well as 
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intracellularly as when the plasma membrane invaginates around a phagocytic target. 
During membrane invagination, granules fuse with the budding phagosomes. Once 
phagosome formation is complete, NOX is activated and generates a large 
intraphagosomal ROS burst [48]. As superoxide dismutates into peroxide, it encounters 
myeloperoxidase which catalyzes the formation of bleach (HOCl) which is thought to kill 
the bacteria [49]. Additionally, the large ROS influx is thought to setup an ionic gradient 
that results in K+ influx which releases granule proteases from their inactivating matrix so 
that they may digest the bacteria [50].  
 
In addition to their phagocytic activity, PMNs are also known to produce Neutrophil 
Extracellular Traps (NETs). NETs can be composed of either nuclear or mitochondrial 
DNA [51, 52]. Their function is to help sequester microbes in a manner similar to that of 
a spider’s web. Bacteria bound by NETs cannot disseminate and represent easy targets 
for elimination. 
 
Monocytes and macrophages have a less pronounced ROS burst than PMNs [53, 54] and 
ROS may not be essential for macrophage bacterial killing as NOX deficient 
macrophages were equally capable of killing bacteria as their wild type counterparts [55]. 
Furthermore, whereas PMNs have prepackaged granule proteases to deliver to the 
phagosome, macrophages rely on an endosomal-like maturation process that results in 
decreasing phagosomal pH and eventual fusion with lysosomes to destroy their cargo 
[56]. Although differences exist in the extent to which neutrophils and macrophages use 
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ROS for microbial killing, the absence of NOX activity, such as in Chronic 
Granulomatous Disease (CGD), underscores the importance of ROS in fighting infection 
[47]. However, it must be kept mind that ROS is not just a byproduct of an intense 
inflammatory reaction; it is also a specific signaling molecule responsible for various 
actions such as chemotaxis [57], gene transcription [58], granule release from 
inactivating matrix [59], and endothelial cell function [60]. 
 
A frequently used measure of bactericidal potential comes from measuring the magnitude 
of the ROS burst from phagocytes. Recently it was shown that neutrophils from CLP 
mice displayed a decreased ROS burst 3-days post CLP, but this impairment returned to 
normal by day 7 post-CLP. The group also showed that Day-3 mice were much more 
susceptible to pneumonia than day 7 mice  [61]. However, other groups have shown 
NOX-derived ROS to contribute to disease pathogenesis and mortality in sepsis[62]. 
Similarly the process of phagocytosis has been shown to be impaired in sepsis due to 
decreased SR expression [63], decreased FcγRIII (CD16) expression on PMN released 
from the bone marrow [64], or even due to PMN mediated suppression of inflammatory 
monocytes via PMN derived IL-10 [65].  
 
The aforementioned studies indicate that modulation of phagocytosis and ROS generation 
occur in sepsis, but these studies compare sham operated animals to CLP. While this 
approach is sufficient for examining the host response to sepsis, we are interested in the 
differences between survivors and non-survivors of sepsis. Our group previously found 
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that six hours post-CLP, the peritoneal cavity of both Live-P and Die-P mice contain 
similar numbers of neutrophils and macrophages (phagocytes), and bacterial CFUs. Yet 
by 24 hours post-CLP, Die-P mice have significantly more peritoneal phagocytes and 
CFUs [44]. These results form the basis for this study and our hypothesis that Mice 
Predicted to Die during the Acute Phase of Sepsis have Cellular Alterations that Impair 
Bacterial Killing. 
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2 CHAPTER TWO: PERITONEAL PHAGOCYTE FUNCTION IN THE CLP 
MODEL OF SEPSIS 
Introduction 
2.  
Sepsis is an immune mediated immune disorder that costs society approximately $24 
billion annually [2], and claims over 200,000 lives per year [66]. Despite being on par 
with cancer in lives lost, there are few treatment options available. Currently, patients 
receive an aggressive treatment of fluid resuscitation, vasopressors, and broad spectrum 
antibiotics [26]. Despite these interventions, post-mortem studies revealed the majority of 
patients still had an infectious foci present [67], thus suggesting a deficit in bacterial 
clearance. 
 
Neutrophils and macrophages comprise the phagocytic arm of the immune system and 
are largely responsible for eradicating a bacterial infection. Following infection, tissue 
macrophages engage the pathogen and secrete distress factors to recruit neutrophils and 
inflammatory monocytes. Neutrophils help to neutralize the infection by secreting 
Neutrophil Extracellular Traps (NETs) [68], and/or by phagocytizing microbes and 
exposing them to Reactive Oxygen Species (ROS) and cationic proteases [69]. Similarly, 
macrophages and inflammatory monocytes phagocytize microbes and process them in a 
manner similar to endosomal cargo, ultimately fusing with lysosomes and digesting the 
bacteria via pH sensitive proteases [56]. As the first responders in an immune response, 
they are central to the initiation of sepsis. 
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Cecal Ligation and Puncture( CLP) induced peritonitis in mice produces a rampant 
inflammatory response that is thought to become dysregulated, leading to immune 
paralysis, bacterial overgrowth, and death [70]. Studies have shown that altering 
leukocyte recruitment [71], or enhancing leukocyte function result in decreased bacterial 
burden [72], increased organ perfusion [73, 74], and ultimately increased survival. 
However, the majority of these studies compare sham-operated animals to CLP-operated. 
This approach is well-suited to define the host response to sepsis, but it may be less 
appropriate for delineating the mechanisms of sepsis mortality. 
 
Previous studies have shown that within 6hrs of CLP, circulating biomarkers can be used 
to accurately predict mortality during the acute phase of sepsis [75]. This powerful 
capability enables stratified interventions to assess efficacy [76, 77] and it provides 
windows of time in which to observe the detrimental divergences between survivors and 
non-survivors. This approach revealed that similar peritoneal bacterial CFUs and 
phagocyte recruitment occurs 6hr post-CLP. Yet by 24hr, non-survivors recruited 
significantly more phagocytes and yet they also showed significantly increased bacterial 
burden [22].  
We hypothesized that non-survivor phagocytes were impaired in their bacterial killing 
capacity. 
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Methods 
Animals 
Female ICR (CD-1) mice (Harlan-Sprague Dawley, Inc., South Easton, MA) between 24-
28 grams were used for all studies. Mice were received and allowed to acclimate to our 
housing room for at least 96 hours prior to surgery. Mice were kept in a temperature and 
humidity controlled room with a diurnal cycle of 12 hours light, 12 hours dark. Mice 
were given food and water ad libitum for the entire duration of the experiment. The 
experiments were approved by the Boston University Animal Care and Use Committee. 
 
Sepsis Model 
Cecal ligation and puncture was performed as first described[29] with minor 
modifications[41]. Mice were first anesthetized in an induction chamber with 5% 
isofluorane, followed by 3% for maintenance during surgery. A midline incision was 
performed through the skin and then the linea alba. The cecum was exteriorized and 
ligated below the illeocecal valve with 4-0 silk. Approximately two-thirds the length of 
the cecum from the distal tip was ligated, then double punctured longitudinally with a 16 
gauge needle. A small amount of cecal contents was squeezed out to ensure patency, then 
the cecum was returned to its original position. The abdomen was closed with 4-0 silk 
sutures, and the skin closed with wound glue (Nexaband- Veterinary Products 
Laboratories, Phoenix, Az). Mice were resuscitated with 1mL warm saline (37°) with 
buprenorphine (0.05mg/kg) for pain management (1 injection every 12hours for the first 
two days post-CLP). Antibiotic treatment with 25mg/kg Imipenem was administered 2 
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hours post-CLP, and then once every 12 hours for the first 5 days. Mice sacrificed at 6 
hours received one dose of drugs, while mice sacrificed at 24 hours received 3 doses.  
 
Sampling 
Blood sampling was performed at 6 and 24 hours to generate IL-6 Receiver Operator 
Characteristic curves. For all other experiments, sampling was performed once at 6 or 24 
hours, according to the planned experiments. 20uL of blood was collected by facial vein 
puncture and diluted 1/10 in PBS containing 3.38mM EDTA tripotassium salt, and 
immediately placed on ice. Blood was centrifuged for 5 min at 1000 X g at 4°C, and the 
plasma was collected and frozen at -20°C until subsequent analysis for IL-6.  In the mice 
that were sacrificed, blood was collected from the retro-orbital venous plexus under 
anesthesia (87 µg/g Ketamine and 13 µg/g Xylazine in normal saline), followed by euthanasia 
via cervical dislocation. The peritoneal cavity was then lavaged with 1mL warm Hanks’ 
Balanced Salt Solution (HBSS, Mediatech Inc., Herndon, VA) containing 10U/mL 
Heparin, followed by 20mL cold HBSS with 0.5mM EDTA and strained through a 70uM 
strainer. 100uL of the 1st mL was used for bacterial cultures. Then the two lavage 
samples were centrifuged separately and the supernatant of the first wash was saved for 
future use. The cell pellets were then resuspended in 2mL wash buffer (PBS + 0.5% 
Bovine Serum Albumin) and 100uL retained for total cell counts and cytospins. The 
remaining cell volume was underlaid with 2mL 30% sucrose (w/v) in PBS and then 
centrifuged for 8 minutes at 450 X g to remove extracellular bacteria [78]. The 
supernatant containing bacteria was aspirated and the cell pellet was resuspended in 3mL 
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wash buffer. 1mL of 100% isotonic Percoll in PBS was added to cell volume to generate 
a 25% Percoll solution. This was underlaid with 1mL Histopaque 1.119 and then 
centrifuged for 25 min at 500 X g. The viable cells were located at the Percoll Histopaque 
interface. Light debris was aspirated from the 25% Percoll layer, dead cells were 
removed from the pellet by pipette, and the remaining viable cells were washed once, 
followed by resuspension in HBSS containing Ca2+ and Mn2+ + 1% BSA. Total cell 
counts were performed with a Beckman-Coulter particle counter model ZF (Coulter 
electronics Inc., Hialeah, Fl).  
 
Bone Marrow cells were flushed from the two hind tibias with cold HBSS + heparin 
using a 25 gauge needle. Cells were centrifuged, the pellet lysed with 1mL 0.2% 
hypotonic saline for 40 seconds, then restored to isotonicity with 1.6% hypertonic saline. 
Cells were washed once and then counted. 
 
Bacterial Cultures 
100uL of the 1st mL of lavage fluid was serially diluted with HBSS 1:10 to 1:10 and 
50uL of each dilution were cultured on 5% sheep blood agar plates (Fisher Scientific). 
Plates were incubated for 24 hours at 37°C in anaerobic or aerobic conditions and then 
the number of Colony Forming Units (CFU) was counted. 
 
ELISA 
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An aliquot of 1/10 diluted plasma collected at 6 and/or 24 hours was diluted 1/5 in 
dilution buffer for a final dilution of 1/50, and then analyzed for IL-6 concentrations by 
ELISA as previously described [79].  
 
Bacterial Killing 
Streptomycin resistant Escherichia coli (E. coli strain HB101) were grown to log-phase in 
Tryptic Soy Broth containing streptomycin. Bacteria were opsonized with normal ICR 
mouse plasma for 20 minutes at 37°C at which point they were directly added to 
peritoneal cells (4*106/ml) at a 5:1 microbe: cell ratio. Cells/E.coli were centrifuged at 
50*g for 5 minutes to facilitate contact. Cells/E. coli were then incubated for 1 hour at 37 
°C. The reaction was stopped by lysis with H2O pH 11 [80]. Serial dilutions were plated 
on Tryptic Soy Agar plates infused with streptomycin and grown overnight at 37°C in 
aerobic conditions. The % bacteria killed was calculated by dividing CFUs of sample + 
bacteria by CFUs of bacteria alone. 
 
pHrodo and ROS Measurement 
Heat killed pHrodo-red E.coli (Life Technologies, Carlsbad, CA) were opsonized with 
E.coli specific antibodies. Bacteria were incubated with peritoneal cells (4*106/ml) at a 
20:1 ratio for 30 minutes at 37°C. pHrodo fluorescence was calculated as gMFI of cells 
incubated at 37°C minus the gMFI of cells incubated on ice. 
ROS was measured by the conversion of non-fluorescent Dihydrorhodamine 1,2,3 (DHR-
123) to fluorescent R-123. Cells were loaded with 2uM DHR-123 and stimulated with 
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opsonized heat-killed E.coli or 100nM Phorbol-12 Myristate-12 Acetate (PMA). PMA 
stimulation was limited to 20minutes. The magnitude of the ROS burst was calculated by 
the % increase of R123 fluorescence (gMFI) of stimulated cells over unstimulated cells. 
Reactions were stopped by placing cells on ice, followed by extracellular marker staining 
for flow cytometry. 
 
3X-Labeled Bacteria Preparation 
Labeling was performed as previously published[81]. Briefly 2*1010/mL of heat-killed 
(80°C 1hr) HB101 E.coli (same strain used for bacterial killing assay) were sequentially 
labeled with 50uM DCF-SE, 50uM pHrodo-SE, and 159uM Alexafluor-350-SE (Life 
Technologies). Labeling was performed in PBS pH 9.0, degassed and purged with N2 to 
minimize auto oxidation of DCF. Bacteria were washed 3X with PBS pH 8.0, and 
resuspended in PBS pH7.4 (N2) and stored in glass vials flushed with N2. Bacteria 
(~1.5*1010/mL) were opsonized with 1/10th volume of normal mouse plasma 
(heparinized) and anti-E.coli antibodies (50ug/mL) (Life Technologies). 
 
3X-Labeled Bacteria Phagocytosis 
Peritoneal cells were loaded into polypropylene cryovial tubes at 4*106/mL. While on 
ice, ~150 bacteria/cell were added to cells (10uL of OD600 = 0.105). DNAse was added 
(50ug/mL) to prevent aggregation of cells. Tubes were transferred to a water bath at 
37°C, placed on heated stir plate, and agitated at lowest speed for 30minutes with 7x2mm 
micro stir bars. For controls, samples were also incubated on ice for 30 minutes. 
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Following incubation, all cells were kept on ice until data acquisition with a flow 
cytometer. No wash steps were performed. 
 
Flow Cytometry 
All data was acquired on an LSRII (BD Biosciences). 
pHrodo/ DHR-123- Cellular FcReceptors were blocked with Fc Block (Bd Biosciences). 
The following antibodies were used: CD11b (clone M170), CD19 (1d3), CD3e (145-
2C11), Ly6G (1A8), Gr-1 (RB6-8C5), F480 (Ci-A13), Ly6C (HK1.4). Only Sytox Blue 
negative events (Live Cells) were used for gating. Doublet discrimination was performed 
by Fsc-A vs Fsc-H. BD compensation beads (BD biosciences) were used for 
compensation. Additionally, Sytox Blue and R-123 were used to stain cells and compared 
to unstained cells for compensation against those parameters.  
 
3x Labeled Bacteria- DCF, pHrodo, and Alexafluor-350 fluorescence was collected by 
(wavelength/band pass) 530/15, 590/10, and 450/50 filters. It was important to use a 
custom 590/10 filter for pHrodo because Trypan Blue auto fluoresces when bound to 
protein and its emission begins at ~615nm. The stock filter supplied by the core facility 
was a 610/20bp.  
 
Initial PMT settings were chosen such that the MFI of pHrodo and Alexa-350 had a 1:1 
ratio. DCF PMT was set between 0-100 (DCF has little fluorescence prior to oxidation). 
Once the bacterial settings were in place, a positive control (healthy cells + 3x bacteria) 
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was acquired to ensure all events were on scale. PMTS were adjusted as needed, and then 
“locked in” with calibration particles. Prior to sample acquisition, Spherotec rainbow 7-
peak calibration particles were run to ensure that the PMT settings used were appropriate 
(<±5% of the first experiment’s MFIs). 3x bacteria were also collected for quality control 
purposes. Equal volumes of beads, bacteria, and diluent (PBS) were used, and events 
were acquired at the same flow rate from day to day.  
 
Ice controls were acquired first. ~20,000 events were collected to measure attachment. 
Then, Trypan Blue was added to tube (0.25% Final concentration), incubated on ice for 1 
minute, and then ~30,000 gated events were collected. Cells that were allowed to 
phagocytize were only acquired with TB present. 
 
Data was analyzed with Flowjo (Treestar Inc.). Non-debris cells were gated on by 
Fsc/Ssc. Doublets were removed by fsc-h vs. fsc-w, with care taken to not remove 
activated cells from analysis. Phagocytosis + gates were constructed for each sample 
based off its own ice control (no phagocytosis occurs.) The MFI of quenched ice control 
cells was subtracted from each channel of the 37°C sample, to account for the minimal 
contribution of autofluorescence (minimal because the PMTs were set low enough to get 
positive single bacterial events to read near zero.) Derived parameters were constructed 
within FLowjo so that the DCF or pHrodo fluorescence for each event was divided by the 
fluorescence of Alexa-350 for that event. The ROS index was then calculated by dividing 
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the DCF/Alexa ratio of the cell by the DCF/Alexa ratio of the bacteria. Similar 
calculations were performed for the Acidification Index (pHrodo).  
 
Calcium Signaling 
 Indo-1 loading: Cells were loaded with Indo-1am as previously detailed [82] . 
Briefly, 5-10*106 cells/mL were incubated with 5uM Indo-1am in Krebs-Ringer 
Phosphate (KRP)  for 10 minutes at 37°C, followed by 10 minutes at room temperature. 
Cells were washed and resuspended in complete KRP + 1.5mM MgSO4 + 0.9mM CaCl2. 
Of note, all polypropylene conical vials were washed 3X with 3X Distilled water to 
remove traces of chemical plasticizers which will prematurely activate PMNs. 
 Flow Cytometry: A custom device that allows for thermostating, stirring, and 
stimulus injection was borrowed from the Elizabeth R Simon’s lab and modified to work 
with the LSRII flow cytometry platform. Cells were loaded into the device at 2*106/mL, 
warmed for 2-3 minutes at 37°C, followed by acquisition on the LSRII. Once a steady 
baseline of Indo-1 fluorescence was reached (10-20s), stimulus (~150 bacteria/cell) was 
injected into the sample. Acquisition proceeded for 120s minimum. 
Indo-1 fluorescence was collected with 405/20 (violet) and 500/30 (blue) bandpass filters.  
 
Luminol Chemiluminescence 
Peritoneal cells were added to white-opaque microplate wells in duplicate at a 
concentration of 4*106/mL. Luminol was present at 20uM. Cells were placed in a 
temperature controlled fluorescent plate reader (Tecan Infinite m1000) and warmed to 
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37°C for 5 minutes. Stimulus was then added (100nM PMA, 20:1 bacteria:cell) and 
chemiluminescence was measured every ~10s (0.5s integration time) followed by 
mechanical shaking. 
 
Statistical Analysis 
Statistics were performed using Prism 5 software (Graphpad Software, San Diego, CA). 
For comparison between 2 groups, an unpaired Student t test was used.  
 
Results 
Characterization of CLP-Induced Sepsis: A Similar Beginning, a Dissimilar Fate. 
 
To study the mechanisms of mortality, our lab uses a CLP model that produces 
approximately 50% mortality within the first five days of sepsis (Acute phase) (Figure 
2-1). Monitoring plasma IL-6 levels of survivors/non-survivors shows that mice that 
succumb to sepsis have significantly elevated IL-6 at 24hr post CLP as well as at 6hr 
post-CLP (data not shown). Receiver Operator Characteristic curves were used to 
generate IL-6 discrimination values to stratify mice as predicted to live (Live-P) or 
predicted to die (Die-P), as described previously [75]. With this approach, mice were 
sacrificed at 6hr and 24hr post-CLP and posthumously stratified. 
 
As reported previously by this lab, Die-P mice have similar numbers of bacteria in their 
peritoneum as compared Live-P mice at 6hr Post-CLP (Figure 2-1 D). Similarly, there is 
no difference in overall cell numbers or cell phenotype between Live-P and Die-P groups 
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(Figure 2-1C) [22]. This demonstrates that our CLP model is consistent, but more 
importantly, that both Live-P and Die-P groups were subjected to a similar initial insult 
with a similar cellular response. However, by 24hr post-CLP Die-P mice have increased 
bacteria and increased phagocyte recruitment to the peritoneum. The divergence from 
similar phagocyte recruitment and bacterial burden at 6hr post-CLP, to increased 
phagocytes and bacterial numbers at 24hr post-CLP suggests a defect in phagocyte 
function in Die-P mice. 
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Figure 2-1 Phagocyte Dysfunction Precedes Death from CLP-induced Sepsis. (a) 
CLP was performed to induce ~50% mortality in ICR CD1- outbred mice. (b) Plasma 
was collected while animals were monitored for survival. ROC curve analysis was used 
to generate IL-6 values predictive for mortality. (c-d) Peritoneal bacterial loads and 
cellular recruitment between Live-predicted/Die-predicted mice were compared 
following euthanasia at 6 or 24 hours post-CLP. *=p<0.05, ***= p<0.0001 
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Die-P Phagocytes Show Impaired Bactericidal Activity 
When examined for bacterial killing using live E.coli (HB101), Die-P mice showed a 
marked reduction in bacteria killed compared to Live-P mice within 6hr post-CLP and 
this persists through 24hr (Figure 2-2). These data strongly suggest that the early onset of 
reduced bacterial killing precipitates subsequent mortality.  
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Figure 2-2 Die-P Mice Exhibit Impaired Bacterial Killing of E.coli at 6 and 24hr 
post-CLP. Data from at least 3 independent experiments. N=7-13/group at 6hr, 7-8/group 
at 24hr, where N represents an individual mouse. ***= p<0.0001  
 
To determine why Die-P peritoneal phagocytes kill fewer bacteria than Live-P, the 
bactericidal mechanisms were further examined. ROS generation is integral to the 
microbial killing process, as evidenced by those with Chronic Granulomatous Disease 
(CGD), a condition where patients are prone to recurrent bacterial infections due to a 
mutation that renders the ROS producing NADPH Oxidase (NOX) complex inoperable. 
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To assess NOX activity, peritoneal cells were stimulated with opsonized bacteria or 
PMA, and then analyzed by flow cytometry. 
 
Neutrophils were defined as (CD11b+, LY6G Hi) and monocytes/macrophages were 
defined as CD11b+, LY6G lo/neg (Figure 2-3) [83, 84]. Though the analyzed macrophage 
population expressed the classical macrophage marker F4\80, its variable level of 
expression in Die-P (Figure 2-3, G) mice made its use unsuitable for gating purposes. 
This fits with recent work published by Misharin et al where it was shown that 
eosinophils express F4\80, and, inflammatory conditions induced by thioglyocollate 
result in decreased F4\80 expression by macrophages [85]. This is likely due in part to 
newly recruited monocytes/macrophages that express little F4\80 [86].   
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Figure 2-3 Flow Cytometry Gating Strategy for Peritoneal Phagocytes. A-C: 
Removal of debris, doublets, and dead cells. D-F: Neutrophil & Monocyte/Macrophages 
(Macs) identified as (Cd11b+, Cd3e/Cd19-) LY6G-Hi or LY6G-Low, respectively. G: 
Fluorescence Minus One (FMO) staining of LY6G-low cells shows variable F480 
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staining on LY6G-low cells (Die-P, Red; Live-P, Blue; Naïve Resident Macs, Orange; 
FMO controls shaded). 
 
 
Within 6hr post-CLP, both Die-P neutrophils and Die-P macrophages produce 
significantly less ROS than their Live-P counterparts in response to Opsonized E.coli (O-
E.coli) ( Figure 2-4 A-C), and this deficiency persists through 24hr post-CLP. The use of 
O-Ec as a stimulus is physiologically relevant; it measures how a cell would likely 
respond in-vivo when encountering cecal bacteria. This process leads to NOX activation 
subsequent to cell surface receptor ligation and signaling. However, if there is decreased 
receptor expression, desensitization, or some other means of blunted receptor signaling, 
NOX may fail to activate despite being fully capable to do so. To determine if the 
differences in NOX mediated ROS were due to impaired PRR signaling, or decreased 
capacity of intracellular NOX to activate and generate ROS, PMA was used to stimulate 
the cells. PMA is a non-specific activator of NOX, which bypasses the requirement of 
PRR signaling for NOX activation.  Following PMA stimulation, Die-P phagocytes were 
shown to be capable of generating ROS, albeit significantly less so than Live-P at both 
time points (Figure 2-4 D,E). 
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Figure 2-4: Die-P Peritoneal Phagocytes have Decreased ROS Burst. A: 
Representative histograms for Rhodamine 1,2,3 fluorescence (ROS) of cells incubated 
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with (red histogram) or without stimulus(blue) at 37°C for 30min. B-C: Physiological 
ROS Burst via opsonized bacteria stimulus. D-E: Cellular Capacity for ROS Burst via 
PMA stimulus. N=4-7 per group from 3 independent experiments, where N represents an 
individual mouse. 
 
 Interestingly, Die-P phagocytes produce less ROS in response to O-E.coli stimulation 
than they do if left unstimulated, relatively. It is important to note that “unstimulated 
control” cells are not naïve cells; they were harvested from the peritoneums of mice 
undergoing extreme peritonitis. These cells are already stimulated, but even so, there are 
significantly different responses at 6hr post-CLP, a time at which bacterial loads (i.e. pre-
assay stimulation) are similar. A caveat to end-point measurements for ROS lies in that 
our analysis, and many others’, employ normalization to an unstimulated control that is 
producing basal ROS. Since these cells were procured from inflamed tissue, it may be 
that Die-P phagocytes generate less ROS than Live-P because the Die-P cells are already 
generating maximal ROS (i.e.hyperstimulated), making any observable increase difficult 
to detect.  To determine if Die-P cells are hyperstimulated, a chemiluminescence based 
kinetic assay was used to measure ROS. Here too, Die-P mice are significantly impaired 
to generate ROS in response to both phagocytosis and PMA (Figure 2-5 B, D-E). 
Furthermore, the basal ROS data suggests that Die-P cells are not hyperstimulated, but 
may instead be exhausted or suppressed (Figure 2-5 A,C). 
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Figure 2-5 Die-P Peritoneal Cells are not Hyperstimulated. Representative ROS 
Kinetics for unstimulated (A), O-E.coli (B) and PMA (C) stimulated cells for Live-P and 
Die-P mice, as measured by Luminol based chemiluminescence (RLU). Area Under the 
Curve was calculated for samples E. coli (D) and PMA (E) burst. (N=3 mice / group). 
Samples were assayed in duplicate wells (D). *=p<0.05, **=p<0.01,***=p<0.001  
 
Diminished ROS generation alone does not explain decreased bacterial killing, as 
macrophages with defective NOX and inducible nitric oxide synthase (iNOS) enzymes 
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can still phagocytize and kill bacteria as well as their NOX/iNOS competent counterparts 
[55]. This is because, following internalization, the phagosome acidifies and enables pH-
sensitive antimicrobial products to destroy the phagosome’s microbial cargo. Thus, 
impaired ROS generation alone may not account for the impaired bacterial killing 
observed in Die-P mice. In light of this, phagocytosis was examined by pHrodo labeled 
E.coli. pHrodo is a fluorophore with low fluorescence at neutral pH but whose 
fluorescence intensity increases with decreasing pH. 
 
Following incubation with pHrodo:E.coli, Die-P neutrophils and macrophages show 
significantly less pHrodo fluorescence (Figure 2-6) at both time points, suggesting 
decreased phagocytosis overall. However, pHrodo is pH sensitive and phagosomal pH 
conditions vary, potentially confounding pHrodo data interpretation. As such, the term 
“pHrodocytize” is used in lieu of phagocytosis to reflect this.  
 
Taken together, these data indicate that the failure of Die-P cells to generate bactericidal 
conditions (ROS) or internalize bacteria (pHrodo) result in decreased bacterial killing in-
vivo and ex-vivo, leading to death.  
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Figure 2-6 Die-P Phagocytes “pHrodocytize” Less. Die-P peritoneal neutrophils 
phagocytize less pHrodo-E.coli at 6 and 24hr post-CLP. Macrophages phagocytize less at 
24hr post-CLP.  N=4-7 per group from 3 independent experiments where N represents an 
individual mouse. *=p<0.05, ***=p<0.001 
 
 
 
Die-P Phagocytes are Immunosuppressed 
The preceding data suggest that Die-P phagocytes are impaired as compared to Live-P, 
but the data does not indicate how or why they are impaired. It may be that Die-P cells 
are exhausted, meaning that the majority of their cells are refractory to stimulus and any 
activity that is observed comes from only a subset of cells responding. Alternatively, a 
similar percentage of cells between groups may respond to stimulus, but Die-P cells are 
weaker in their response, meaning that they are actively suppressed in their function  
To determine this, a saturating dose of labeled bacteria was used to stimulate the 
peritoneal phagocytes. It was important to use a saturating dose of bacteria in order to 
ligate all available receptors because, despite equal binding of ligand by all cells, only a 
subset of cells will actually respond (i.e. phagocytize) [82]. A saturating dose induces the 
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maximum proportion of cells to respond. In conjunction with Trypan blue, cells that have 
internalized bacteria can be discriminated from those that have not. 
 
Using a saturating dose, similar proportions of cells phagocytize the bacteria at both time 
points (Figure 2-7 B,D). However, Die-P cells phagocytize significantly less bacteria 
overall than Live-P at both time points (C,E). The term phagocytic strength is used to 
reflect the amount of internalized bacteria, as calculated by the gMFI of phagocytosis+ 
events after quenching of extracellular bacterial fluorescence by trypan blue. These data 
suggest that Die-P peritoneal cells are suppressed in their function, but they are not 
exhausted since a similar percentage of cells do phagocytize, albeit significantly less than 
seen in Live-P.  
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Figure 2-7 Die-P Phagocytes Are Suppressed in Phagocytosis. Gating for 
Phagocytosis+ events: Ice control left, 37°C incubation right.Trypan blue was used to 
quench extracellular fluorescence (A). 6hr post-CLP, the percentage of Peritoneal cells 
from Live-P and Die-P mice that phagocytize bacteria (B), and overall amount of bacteria 
internalized (C). 24hr post-CLP (D,E) Data collected from 3-4 independent experiments. 
N=4/group for 6hr, N=5-7/group for 24hr, where N represents an individual mouse. 
*p<0.05, ***p<0.0001 
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Decreased phagocytosis could be due to decreased attachment of the bacteria to the cell 
surface. However, this does not appear to be the case as both groups’ exhibit similar 
levels of bacterial fluorescence when incubated on ice and without addition of TB (Figure 
2-8). 
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Figure 2-8 Attachment of Bacteria to Cell Surface. No significant difference exists in 
binding of bacteria to the phagocyte cell surface 6hrs post-CLP. N=4/group from 3 
independent experiments, where N = an individual mouse 
 
In the same set of experiments, intraphagosomal processes were examined to determine 
the extent of the suppression and see whether once inside, bacteria were still exposed to 
the harsh microbicidal environment. This was accomplished using a recently developed 
technique in which E.coli were simultaneously labeled with Dichlorofluorescein (ROS 
sensor), pHrodo, and Alexafluor-350 (ROS/pH insensitive). Since TB quenching made 
extracellular staining for Mac/PMNs impractical, cellular responses were subdivided into 
High ROS and Low ROS cells. This was done by dividing each event’s DCF 
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fluorescence by its Alexafluor-350 fluorescence. In this manner, DCF fluorescence can 
be attributed to the amount of oxidation, and not to differences in the amount of labeled 
bacteria within the cell. A similar approach was used to determine phagosomal 
acidification, but with pHrodo normalized to Alexafluor-350. It was important to 
subdivide the cell populations so that small differences in a subset of cells would not 
potentially be masked by no differences in the majority of the cells. Furthermore, high 
ROS cells are loosely considered PMN and Low ROS cells are considered macrophages. 
This is based on the propensity of PMN to produce increased ROS [53], while 
macrophages have more phagosomal acidification [54], and the macrophage’s increased 
capacity for phagocytosis owing to its ability to synthesize new granule proteins [87] 
(Figure 2-9).  
To determine if the decreased phagocytic strength of Die-P cells was due to decreased 
phagocytosis by either macrophages or neutrophils, the peritoneal phagocytic strength 
data (Figure 2-7 C,E) was re-examined by first stratifying the cell populations based on 
High or Low phagosomal ROS production (Figure 2-9, top panel). This approach shows 
that both Die-P neutrophils and macrophages are suppressed in their ability to 
phagocytize. 
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Figure 2-9 Gating for Putative Neutrophils and Macrophages based on Phagocytic 
Activity. Above-Contour Plot for Phagocytosis+ events, showing normalized ROS and 
pH fluorescence with High ROS as neutrohpils and Low ROS cells as macrophages. 
Below- The Phagocytic strength, or overall amount of internalized bacteria, for 
High/Low ROS cells was calculated via its Alexa-350 fluorescence. *p<0.05,**p<0.01 
***p<0.001 N=4 at 6hr and 5-7 at 24hr from 3 independent experiments, where N = an 
individual mouse 
 
As observed with phagocytosis, Die-P peritoneal phagocytes show decreased phagosomal 
maturation as compared to Live-P (Figure 2-10). Although significant differences in 
phagocytosis exist by 6hr, there are not significant differences in phagosomal ROS or pH 
in PMNs. However, there is significantly less phagosomal acidification in Die-P 
macrophages within 6hr (Figure 2-10 C), thus suggesting that multiple bactericidal 
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processes are suppressed soon after sepsis begins.  By 24hrs post-CLP, the suppression of 
phagosomal maturation is more evident. Die-P PMNs produce significantly less 
phagosomal ROS, in addition to decreased phagosomal acidification (Fig 2-11 A-B). 
Similarly, Die-P macrophages continue to show significantly less phagosomal 
acidification when compared to Live-P macrophages (Fig 2-11 C). Taken together, these 
data strongly suggest that Die-P phagocytes are suppressed in their ability to internalize 
bacteria, and to create the harsh conditions necessary to kill internalized bacteria. 
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Figure 2-10 Die-P Peritoneal Phagocytes are Partly Suppressed in Phagosomal 
Maturation, 6hr Post-CLP. A, PMN phagsomal ROS was calculated by normalizing 
DCF (ROS sensitive) fluorescence to Alexa-350 fluorescence (ROS/pH insensitive). B, 
PMN phagosome acidification was calculated by normalizing pHrodo fluorescence to 
Alexa-350. C, Macrophage phagosome acidification. *p<0.05 N=4 from 3 independent 
experiments, where N = an individual mouse 
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Fig 2-11 Die-P Peritoneal Phagocytes are Suppressed in Phagosomal Maturation, 
24hr post-CLP. A, PMN phagsomal ROS was calculated by normalizing DCF (ROS 
sensitive) fluorescence to Alexa-350 fluorescence (ROS/pH insensitive). B, PMN 
phagosome acidification was calculated by normalizing pHrodo fluorescence to Alexa-
350. C, Macrophage phagosome acidification.. *p<0.05,**p<0.01 ***p<0.001 N=5-7  
from 3 independent experiments, where N = an individual mouse. 
 
Calcium Signaling 
Decreased phagocytosis and phagosomal function despite similar attachment of bacteria 
to the cell suggest that the signal to phagocytize is not propagated. Intracellular calcium 
is a key second messenger whose release from internal stores or extracellular influx 
drives a range of cellular processes. Decreased phagocytosis and phagosomal function 
despite similar attachment of bacteria to the cell suggest that the signal to phagocytize is 
not propagated [88, 89].   
 
 To determine if impaired Ca2+ signaling contributes to impaired phagocyte function in 
Die-P mice, cells were assayed for their ability to generate a calcium flux. Cells were 
loaded with the ratiometric probe, Indo-1 and subsequently stimulated with a saturating 
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dose of bacteria. Confirming earlier reports [90], a dose of 100-200 bacteria per cell was 
found to generate the maximum change in the Indo-1 ratio (Figure 2-12).   
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Figure 2-12 Determination of Saturating Dose of Bacteria. A,B- Typical Indo-1 
fluorescence shifts for Naive PMN stimulated with opsonized E. coli. C, A derived 
parameter of Indo-1 (violet) / Indo-1 (blue) was constructed to visualize calcium flux. D, 
Kinetic plots of the Indo-1 ratio for several doses of bacteria show dose/response 
saturation. Arrows indicate time of stimulation 
 
  
These preliminary studies were performed in naïve PMN isolated from bone marrow. 
However, when peritoneal cells from septic mice were used, a reliable calcium flux could 
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not be observed. This could be due to the cells being pre-activated and in a continuous 
state of activation, as suggested by the large spread in Indo-1 fluorescence prior to 
stimulation (Figure 2-13 A, B). This renders the calculation of baseline to peak indo-
1fluorescence shifts impractical. Furthermore, when viewing kinetic plots of some 
samples, a calcium flux appeared (Figure 2-13 C), as determined by the increase in the 
Indo-1 ratio. This occurred in the absence of commensurate increases and decreases in 
the Indo-1 violet and Indo-1 blue fluorescence, respectively (Figure 2-13 D, E). This 
suggests that other unknown factors influenced the Indo-1 ratio calculation such that it 
was not a suitable measure for the binding and releasing of Ca2+. 
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Figure 2-13 Calcium Signaling is not Suitable for Cells from Infectious Foci. Indo-1 
plots shows broad range of fluorescence (A,B) before and after stimulation with  
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fluorescently labeled (TRITC) E. coli (C). Kinetic plots of Indo-1 ratio (D), Indo-1 Violet 
(E) and blue (F) show discordant responses of increasing violet emission without 
commensurate decrease in blue emission. Arrows indicate time of stimulus. Data 
representative of several experiments. 
 
To conclude these results, a color coded table was created to illustrate all the differences 
and similarities between Live-P and Die-P mice at both time points (Table 2-1) 
 
 
 
 
 
 
 
Neutrophils Macrophages Peritoneal Cavity 
6hr 24hr 6hr 24hr 6hr 24hr 
pHrodocytosis             
O-E.coli Mediated ROS             
PMA Mediated ROS             
% of cells phagocytizing             
Phagocytic Strength * * * *     
Phagosomal ROS * * * *     
Phagosomal Acidification * * * *     
Cell #             
Bacterial CFU             
Bacterial Killing             
  Decrease Relative to Live-P 
  Increase Relative to Live-P 
  No significant difference 
  Not Applicable 
* Indicates Putative Cell Type 
Table 2-1: Results Summary for Die-P mice, as compared to Live-P. Peritoneal cavity 
ROS results (right most column) obtained from Luminol based chemiluminescence, * 
indicates results for the putative cell type based since extracellular cell staining could not 
be performed (see Figure 2-9 Gating for Putative Neutrophils and Macrophages 
based on Phagocytic Activity. Above-Contour Plot for Phagocytosis+ events, showing 
normalized ROS and pH fluorescence with High ROS as neutrohpils and Low ROS cells 
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as macrophages. Below- The Phagocytic strength, or overall amount of internalized 
bacteria, for High/Low ROS cells was calculated via its Alexa-350 fluorescence. 
*p<0.05,**p<0.01 ***p<0.001 N=4 at 6hr and 5-7 at 24hr from 3 independent 
experiments, where N = an individual mouse for details.)  
 
 
 
 
Discussion 
The most important finding in this study is that despite receiving equivalent inoculums 
and recruiting similar numbers of phagocytes in response to the inoculum, Die-P 
peritoneal phagocytes are impaired in their ability to kill bacteria. This provides strong 
evidence that the CLP model can be standardized, which has been a point of concern 
within the community [91]. Less obvious but of equal concern to other investigators is 
that without proper stratification of mice according to their likelihood of survival, 
considerable variability will permeate their studies. For example, cell function, organ 
injury, bacteria, and cytokines have been shown to differ significantly between survivors 
and non-survivors [75, 92]. Stratification would be of considerable benefit in human 
studies where heterogeneity in individuals and their responses are more pronounced. In 
support of stratification and our findings of decreased bacterial killing preceding death, 
Danikas et al showed phagocytic activity as prognostic for outcome in human sepsis [93]. 
 
While numerous studies have argued for and against organ injury preceding death from 
sepsis [92, 94, 95], this study strongly suggests that it is phagocytic impairment early on 
(within 6hr) that ultimately leads to uncontrolled microbial growth and death. This is 
despite the use of broad spectrum antibiotics. It may be that failure to contain the initial 
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infection allows the intense inflammatory reaction to ripple throughout the organism, 
leading to organ injury. The successful eradication of microbial pathogens requires 
recruitment of myeloid cells to the site of infection [96, 97]. To that end, other labs have 
shown that increasing or inhibiting neutrophil recruitment following CLP [98, 99] affects 
bacterial burden and animal survival. Our lab has shown that prior recruitment of 
neutrophils also increases survival [22]. However, that study and this one demonstrate 
that the mice that are predicted to die do not fail to recruit neutrophils or 
monocytes/macrophages as compared to the mice predicted to live. In fact Die-P mice 
recruit more cells by 24hr post-CLP. Similar findings were recently reported by another 
lab that used CLP to produce ~ 60% mortality in control mice [100]. In it they 
demonstrated that without GM-CSF producing B-cells, CLP resulted in 100% mortality. 
Most importantly, as it relates to this study, the B-cell GM-CSF-/- mice recruited 
significantly more neutrophils to the peritoneum, yet still had increased bacterial burden, 
increased inflammatory mediators, and decreased phagocytosis as observed in our model. 
Taken all together, this suggests that while phagocyte recruitment is important, their 
functional status is more important. 
 
Although this study strongly argues for impaired phagocyte function as precipitating 
death, it does not address the role of lymphocytes, which are fundamental to an immune 
response. Others have shown that treatments affect lymphocyte apoptosis and function 
resulting in in increased survival [101, 102]. While these studies did not stratify by 
survival likelihood, it is interesting to speculate that impaired lymphocyte function or 
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death is driving the phagocyte dysfunction observed in our model. Certainly the report by 
Rauch et al supports this. Another limitation to this study is that only peritoneal cells 
were evaluated for performance. It would be interesting to know if Die-P phagocytes 
become impaired upon their arrival to the peritoneum, or if their impairment exists prior 
to their arrival. Delano et al showed that CLP results in suppressed ROS burst by 
monocytic splenocytes and bone marrow neutrophils. It will be important to determine to 
what extent systemic alterations are implicated in a survivor/non-survivor model of 
sepsis. 
 
There is considerable evidence that suggests that overstimulation of cells with 
contradictory stimuli (i.e. pro and anti-apoptosis agents) can result in a terminally non-
responsive state, affectionately termed “zombie cells” [103]. Along similar lines, Die-P 
mice demonstrate a significantly larger surge in pro and anti-inflammatory mediators in 
their peritoneum’s and plasma [22], potentially creating the conditions for terminally 
non-responsive cells that render them incapable of defending the host. In light of this, 
perhaps the most hopeful finding of this study is that Die-P cells are functionally intact 
and equally capable of responding to bacteria, although they are deficient in both the 
amount they can phagocytize and how they process their phagosomal cargo. That they are 
responsive makes them attractive targets for functional modulators, such as antagonists of 
adenosine receptors or programmed death receptor-1, both of which have been suggested 
to increase phagocyte function and improve survival from sepsis [77, 104]. 
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3 CHAPTER THREE: SYSTEMIC ALTERATIONS OF PHAGOCYTE 
FUNCTION IN THE CLP MODEL OF SEPSIS 
Introduction 
Mortality from sepsis increases as its pronounced aberrations spread throughout the body, 
first producing leukopenia, then hypovolemia, Multi-Organ Dysfunction Syndrome 
(MODS) which may culminate in death. The organs most likely to fail are the lungs, 
kidneys, liver and pancreas [66, 105-108]. A key component of sepsis therapy is to 
maintain organ perfusion and blood pressure, with the hope that this provides the host 
enough time to resolve its disordered state. However, current treatments lack 
interventions meant to restore immunological function. 
 
Systemic immunosuppression is increasingly seen as a key mediator of sepsis 
immunopathology [109]. In mice and humans, sepsis results in a profound depletion of 
splenic lymphocytes and dendritic cells [110-112], as well as their functional suppression 
[113]. Similarly in mice, it was shown that CLP induced sepsis leads to decreased 
reactive oxygen species burst (ROS) in splenic and bone marrow granulocytes [114]. 
Although revealing, these studies did not compare non-survivors to survivors of sepsis.  
 
The previous chapter provided evidence why some mice die from CLP while others do 
not: Decreased bacterial killing and bactericidal function by peritoneal phagocytes. This 
does not, however, make the distinction of whether Die-P phagocytes are intrinsically 
inferior to their Live-P counterparts. It may be that phagocyte immunosuppression is 
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localized to the peritoneum, following CLP. Before the phagocytes can engage the 
infection, they must navigate from the bone marrow through the circulation until they 
reach the peritoneum. We sought to determine if Die-P phagocytes are suppressed in their 
function prior to their arrival to the peritoneal cavity. 
 
Methods 
Animals 
Female ICR (CD-1) mice (Harlan-Sprague Dawley, Inc., South Easton, MA) between 24-
28 grams were used for all studies. Mice were received and allowed to acclimate to our 
housing room for at least 96 hours prior to surgery. Mice were kept in a temperature and 
humidity controlled room with a diurnal cycle of 12 hours light, 12 hours dark. Mice 
were given food and water ad libitum for the entire duration of the experiment. The 
experiments were approved by the Boston University Animal Care and Use Committee. 
 
Sepsis Model 
Cecal ligation and puncture was performed as first described [29] with minor 
modifications [41]. Mice were first anesthetized in an induction chamber with 5% 
isofluorane, followed by 3% for maintenance during surgery. A midline incision was 
performed through the skin and then the linea alba. The cecum was exteriorized and 
ligated below the illeocecal valve with 4-0 silk. Approximately two-thirds the length of 
the cecum from the distal tip was ligated, then double punctured longitudinally with a 16 
gauge needle. A small amount of cecal contents was squeezed out to ensure patency, then 
the cecum was returned to its original position. The abdomen was closed with 4-0 silk 
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sutures, and the skin closed with wound glue (Nexaband- Veterinary Products 
Laboratories, Phoenix, Az). Mice were resuscitated with 1mL warm saline (37°) with 
buprenorphine (0.05mg/kg) for pain management (1 injection every 12hours for the first 
two days post-CLP). Antibiotic treatment with 25mg/kg Imipenem was administered 2 
hours post-CLP, and then once every 12 hours for the first 5 days. Mice sacrificed at 6 
hours received one dose of drugs, while mice sacrificed at 24 hours received 3 doses.  
 
Sampling 
Blood sampling was performed at 6 or 24 hours, depending on when the animal was 
sacrificed. 20uL of blood was collected during exsanguination via the retro-orbital 
venous plexus and diluted 1/10 in PBS containing 3.38mM EDTA tripotassium salt, and 
immediately placed on ice. The remainder of the exsanguination volume was collected 
into 100uL Heparin (1000U/mL). Blood diluted 1/10 with PBS/EDTA was centrifuged 
for 5 min at 1000 X g at 4°C, and the plasma was collected and frozen at -20°C until 
subsequent analysis for IL-6 to determine if the mice were predicted to live or die.  
Bone Marrow cells were flushed from the two hind tibias with cold HBSS + heparin 
using a 25 gauge needle. Cells were centrifuged, the pellet lysed with 1mL 0.2% 
hypotonic saline for 40 seconds, then restored to isotonicity with 1.6% hypertonic saline. 
Cells were washed once and resuspended in HBSS containing Ca2+ and Mg2+ + 1% BSA. 
Total cell counts were performed with a Beckman-Coulter particle counter model ZF 
(Coulter electronics Inc., Hialeah, Fl). 
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pHrodo and ROS Measurement 
Heat killed pHrodo-red E. coli (Life Technologies, Carlsbad, CA) were opsonized with E. 
coli specific antibodies. Bacteria were incubated with bone marrow cells (4*106/ml) at a 
20:1 ratio for 30 minutes at 37°C. pHrodo fluorescence was calculated as gMFI of cells 
incubated at 37°C minus the gMFI of cells incubated on ice. 
ROS was measured by the conversion of non-fluorescent Dihydrorhodamine 1,2,3 (DHR-
123) to fluorescent R-123. Cells were loaded with 2uM DHR-123 and stimulated with 
opsonized heat-killed E. coli or 100nM Phorbol-12 Myristate-12 Acetate (PMA). PMA 
stimulation was limited to 20minutes. The magnitude of the ROS burst was calculated by 
the % increase of R123 fluorescence (gMFI) of stimulated cells over unstimulated cells. 
Reactions were stopped by placing cells on ice, followed by extracellular marker staining 
for flow cytometry. 
 
3X-Labeled Bacteria Preparation 
Labeling was performed as previously published[81]. Briefly 2*1010/mL of heat-killed 
(80°C 1hr) HB101 E. coli (same strain used for bacterial killing assay) were sequentially 
labeled with 50uM DCF-SE, 50uM pHrodo-SE, and 159uM Alexafluor-350-SE (Life 
Technologies). Labeling was performed in PBS pH 9.0, degassed and purged with N2 to 
minimize auto oxidation of DCF. Bacteria were washed 3X with PBS pH 8.0, and 
resuspended in PBS pH7.4 (N2) and stored in glass vials flushed with N2. Bacteria 
(~1.5*1010/mL) were opsonized with 1/10th volume of normal mouse plasma 
(heparinized) and anti-E. coli antibodies (50ug/mL) (Life Technologies). 
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3X-Labeled Bacteria Phagocytosis 
Bone marrow cells were loaded into polypropylene cryovial tubes at 4*106/mL (final 
volume of 0.25mL). While on ice, ~150 bacteria/cell were added to cells (10uL OD600 
0.105). DNAse was added (50ug/mL) to prevent aggregation of cells. Tubes were 
transferred to water bath 37°C, placed on heated stir plate, and agitated at lowest speed 
for 30 minutes with 7x2mm micro stir bars. For controls, samples were also incubated on 
ice for 30 minutes. Following incubation, all cells were kept on ice until data acquisition 
with a flow cytometer. No wash steps were performed. 
240uL of Peripheral blood was loaded into tubes and given 10uL bacteria, as above. After 
incubation with bacteria, blood was lysed with 12 volumes of Ammonium Chloride lysis 
buffer on ice for 5 minutes and centrifuged at 450 X g for 8 minutes at 4°C. The pellet 
was washed once and resuspended in 250uL HBSS containing Ca2+ and Mg2+ + 1% BSA. 
Cells were strained through 70uM filter prior to flow cytometry. 
 
Flow Cytometry 
All data was acquired on an LSRII (Bd Biosciences). 
pHrodo/ DHR-123- Cellular FcReceptors were blocked with Fc Block (Bd Biosciences). 
The following antibodies were used: CD11b (clone M170), CD19 (1d3), CD3e (145-
2C11), Ly6G (1A8), Gr-1 (RB6-8C5), F480 (Ci-A13), Ly6C (HK1.4). Only Sytox Blue 
negative events (Live Cells) were used for gating. Doublet discrimination was performed 
by Fsc-A vs Fsc-H. BD compensation beads (BD biosciences) were used for 
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compensation. Additionally, Sytox Blue and R-123 were used to stain cells and compared 
to unstained cells for compensation against those parameters.  
3x Labeled Bacteria- DCF, pHrodo, and Alexafluor-350 fluorescence was collected by 
(wavelength/band pass) 530/15, 590/10, and 450/50 filters. It was important to use a 
custom 590/10 filter for pHrodo because Trypan Blue auto fluoresces when bound to 
protein and its emission begins at ~615nm. The stock filter supplied by the core facility 
was a 610/20bp.  
 
Initial PMT settings were chosen such that the MFI of pHrodo and Alexa-350 had a 1:1 
ratio. DCF PMT were set between 0-100 (DCF has little fluorescence prior to oxidation) 
(Figure 3-1). Once the bacterial settings were in place, a positive control (healthy cells + 
3x bacteria) was acquired to ensure all events were on scale. PMTs were adjusted as 
needed, and then “locked in” with calibration particles. Prior to sample acquisition, 
Spherotec rainbow 7-peak calibration particles were run to ensure that the PMT settings 
used were appropriate (<±5% of the first experiment’s MFIs). 3x-labeled bacteria were 
also collected for quality control purposes. Equal volumes of beads, bacteria, and diluent 
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(PBS) were used, and events were acquired at the same flow rate from day to day. 
 
Figure 3-1: 3X-Labeled Bacteria Fluorescence: Histograms are shown to depict how 
PMT gains were set on the flow cytometer to achieve the desired fluorescence of 
individual bacteria. Median fluorescent intensities are shown below the histograms. 
 
Ice controls were acquired first. ~20,000 events were collected to measure attachment. 
Then, Trypan Blue was added to tube (0.25% Final concentration), incubated on ice for 1 
minute, and then ~30,000 gated events were collected. Cells that were allowed to 
phagocytize were only acquired with TB present. 
Data was analyzed with Flowjo (Treestar Inc.). Non-debris cells were gated on by 
Fsc/Ssc. Doublets were removed by fsc-h vs. fsc-w, with care taken to not remove 
activated cells from analysis. Phagocytosis + gates were constructed for each sample 
based off its own ice control (no phagocytosis occurs.) The MFI of quenched ice control 
cells was subtracted from each channel of the 37°C sample, to account for the minimal 
contribution of autofluorescence (minimal because the PMTs were set low enough to get 
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positive single bacterial events to read near zero.) Derived parameters were constructed 
within Flowjo so that the DCF or pHrodo fluorescence for each event was divided by the 
fluorescence of Alexa-350 for that event. The ROS index was then calculated by dividing 
the DCF/Alexa ratio of the cell by the DCF/Alexa ratio of the bacteria. Similar 
calculations were performed for the Acidification Index (pHrodo).  
 
 
Results 
CLP Leads to Alterations in Bone Marrow 
The bone marrow (BM) is the site of myelopoeisis and it contains large reserves of 
neutrophils and monocytes that are released during an infection [115]. Previous studies 
have documented systemic granulocytopenia post-CLP in a sham/CLP model. The same 
study also observed decreased NOX ROS generation by BM granulocytes (CD11b+/GR-
1+ cells, which encompass PMNs and monocytes). It was suggested that these systemic 
alterations account, in part, for increased mortality from a secondary infection [114]. To 
determine if there was a difference in BM “reserves” after CLP that may contribute to 
Die-P mortality, total BM counts, granulocyte frequency, and granulocyte function was 
examined.  
 
Unlike the comparison between sham/CLP mice, there were not significant differences 
between Live-P and Die-P mice when comparing the total number of BM cells retrieved 
(Figure 3-2 A) or the percentage of BM cells that were granulocytes (Figure 3-2 B), 
although there was a marked reduction in cellularity between 6 and 24hr. To determine if 
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BM granulocytes exhibited differences in function, cells were assessed for two 
bactericidal processes: ROS Burst and “pHrodocytosis”- a term meant to reflect the 
increase in pHrodo fluorescence that is due to phagocytosis, but with the caveat that 
differential pH changes within the phagosome could result in different signal intensities 
without there being a difference in the number of pHrodo: bacteria internalized.  
 
There was no discernible difference in BM granulocyte pHrodocytosis or ROS generation 
within 6hr post-CLP (Figure 3-2 C). Interestingly, Die-P cells displayed significantly 
increased bactericidal activity in response to a physiological stimulus (opsonized E. coli) 
by 24hr (Figure 3-2 C,D). However, when assessed for their capacity to generate ROS via 
PMA, a non-receptor based activator, there was no significant difference in ROS (Figure 
3-2 E). This suggests that that while BM granulocytes from Live/Die-P mice have a 
similar capacity to respond, when challenged with a physiologically relevant stimulus, 
their responses differ.  
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Figure 3-2 Die-P Mice Bone Marrow Granulocytes Show Increased Functional 
Response. A, Total number of cells recovered from two hind tibias. B, Percentage of 
bone marrow cells that are granulocytes. C, pHrodo fluorescence of BM granulocytes 
inubated with pHrodo labeled e.coli. D-E, The percent increase in R-123 fluorescence 
intensity of BM granulocytes incubated with E.coli or PMA over cells incubated without 
stimulus. 6hr N= 4-5/group, 24hr N=5-7/group from 3-4 independent experiments, where 
N represents an individual mouse. **=p<0.01 
 
CD11b, a transmembrane protein involved in phagocytosis and adhesion, is widely 
considered as a marker of granulocyte activation [116, 117]. To determine if Die-P BM 
cells are more activated and thus more responsive to bacteria, CD11b expression was 
measured. 24hr post-CLP, Die-P BM granulocytes have significantly increased CD11b 
expression (Figure 3-3), which may partly explain their increased activity. Collectively 
these data suggest that exhaustion of BM granulocyte reserves does not occur in Die-P 
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mice, although hyper-activation of the Die-P BM granulocyte pool may occur between 6 
and 24hr post-CLP.  
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Figure 3-3 Die-P BM Granulocytes Express Significantly More CD11b on Their 
Surface: 24hr post-CLP, there is significantly more CD11b associated fluorescence on 
Die-P BM granulocytes, as compared to Live-P. *p<0.05. N=3-4/group where N 
represents an individual mouse. 
 
Die-P Mice have Reduced Phagocytic Activity in Peripheral Blood 
We next sought to extend our observations in the BM, to the phagocytes circulating in the 
peripheral blood (PB). However, there were insufficient cells recovered to perform the 
assays due to the leukopenia and hypovolemia induced by CLP. To circumvent this, the 
3x-labeled bacteria discussed in the previous chapter were used to determine PB 
phagocyte function in whole blood. Ice controls to prohibit phagocytosis and set 
phagocytosis+ gates (see chapter 2) were not used due to limited blood volume, and 
because cell washing steps were necessary following RBC lysis. Because lymphocytes do 
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not phagocytize and they are prevalent in mouse blood, they were used to set 
fluorescence thresholds for phagocytosis+ events (Figure 3-4). 
High ROS
Low ROS
Granulocytes
Lymphocytes
 
Figure 3-4 Peripheral Blood Gating Strategy: Left Panel, red blood cell debris was 
excluded from analysis. Thick gates show granulocyte and lymphocyte populations. 
Center panel, phagocytosis positive events were identified by high Alexa-350 
fluorescence, relative to non-phagocytizing lymphocytes. Right panel, Normalizing DCF 
(ROS) and pHrodo (Acidification) fluorescence relative to Alexafluor-350 fluorescence 
reveals 2 major populations of High and Low phagosomal ROS. 
 
Incubating whole blood with a saturating dose of bacteria revealed that PB Die-P 
phagocytes phagocytize significantly less bacteria 24hr post-CLP (Figure 3-5), thus 
suggesting there is some degree of phagocyte suppression that exists beyond the 
peritoneum.  
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Figure 3-5 Die-P Peripheral Blood Phagocytes Phagocytize Less Bacteria, 24hr post-
CLP: Left Panel, red blood cell debris was excluded from analysis. Thick gates show 
granulocyte and lymphocyte populations. Right panel, phagocytosis positive events were 
identified by high Alexa-350 fluorescence, relative to non-phagocytizing lymphocytes. 
Bottom Panel, Alexa-350 fluorescent intensity of Phagocytosis+ events reflects the 
overall amount of bacteria internalized (phagocytic strength). **=p<0.01 
 
We next sought to determine if the suppression of phagocytosis extended to the 
subsequent bactericidal mechanisms that are activated within the phagosome. After 
normalizing DCF (ROS sensitive) and pHrodo (pH sensitive) fluorescence to Alexafluor-
350 (ROS/pH insensitive) fluorescence, two major cell populations were observed 
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(Figure 3-4, right panel). Gates were constructed to analyze High ROS and Low ROS 
cells separately so that important phagosomal differences were not obscured. These 
distinct populations may reflect different cell types. Based on the prevalence of High 
ROS cells and their high ROS activity, they are likely PMNs. Low ROS cells are likely 
monocytes as they produce less ROS than PMNs and are less prevalent in the blood of 
mice. 
Looking within the phagosomes, Die-P High ROS cells generate less phagosomal ROS 
than Live-P, while acidifying their phagosomes more (Figure 3-6 A,B). This may be due 
to the decreased ROS production because ROS itself alkalinizes the phagosome.  
Conversely, there is no difference in acidification in Low ROS cells, although their 
overall phagocytic strength is reduced (Figure 3-6 C,D). Collectively these data suggest 
that Die-P phagocytes are suppressed in bactericidal activity prior to their arrival to the 
infection in the peritoneum.  
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Figure 3-6 Die-P Peripheral Blood Phagocytes are Suppressed in Phagoctic Activity, 
24hr post-CLP: A, Phagosomal ROS Index for High ROS cells, calculated by 
normalizing DCF fluorescence to Alexafluor-350 fluorescence. B-C, Phagosomal 
Acidifcation for High or Low ROS cells, calculated by normalizing pHrodo fluorescence 
to Alexafluor-350 fluorescence.DE, Alexa-350 fluorescent intenstity of internalized 
bacteria for High or Low ROS cells. *=p<0.05 **=p<0.01 
 
Phagocytosis initiates when a phagocyte makes contact with a microbe via Pattern 
Recognition Receptors. The most studied of these are the complement and Fc-receptors 
(FcR), which participate in both opsonin dependent and independent phagocytosis [118]. 
To determine whether differential expression of these receptors could account for the 
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differences in phagocytosis observed, peripheral blood cells were stained for FcγRII 
(CD32), FcγRIII (CD16), and CD11b. Somewhat expectantly, Die-P mice had increased 
CD11b expression on peripheral phagocytes (Figure 3-7 C), as was observed for the BM 
cells. Surprisingly, Die-P cells displayed increased FcR expression as compared to Live-
P (Figure 3-7 A,B). For FcR staining, cells were stained first with an antibody to CD16 
and then with antibody that recognized both CD16 and CD32. It is likely that the 
increased CD16/32 (Figure 3-7 B) staining is due to increased expression of CD32 as 
CD16 was pre-blocked with the CD16 antibody.  
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Figure 3-7 Die-P Peripheral CD11b+/Gr-1+ Granulocytes Express More Markers of 
Activation and Inhibtion than Live-P. A, Fluorescence intensity of the Activating 
FcRIII. B, Fluorescence intenstity of the Inhibitory FcR, CD32. C, Fluorescence intensity 
of the activation marker, CD11b. 
 
Discussion 
Our previous study (chapter2) showed that peritoneal phagocytic suppression precedes 
mortality from CLP induced sepsis. This study extended those findings to cellular 
compartments distal to the infection. While many sepsis studies focus on systemic 
alterations, many of these look at particular organs (i.e. lungs, spleen, liver) examining 
organ injury, leukocyte recruitment or adaptive system components [119-122], we 
believe this is the first to compare phagocytic function of cells in route to the infectious 
foci and document the differences between survivors/non-survivors.  
 
This study examined systemic alterations in the context of broad spectrum antibiotic 
administration, which prevents detectable bacteremia. This enabled a look at phagocytic 
function prior to phagocyte: pathogen interaction. One concern that emanated from our 
previous findings in the peritoneum was that the peritoneal environment became 
increasingly hostile towards phagocytic function. Possible reasons for this include the 
increasing cellular debris present in Die-P samples (data not shown), especially by 24hr, 
which may hamper bacterial clearance, and perhaps increased bacterial dissemination 
within the peritoneum. The most important finding from this study is that peripheral 
blood phagocytes from Die-P mice are suppressed in phagocytic activity prior to their 
arrival to the peritoneum. Because the mice used in these studies are heterogeneous 
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outbred mice, it tempting to speculate that the impaired phagocytic function observed in 
the peritoneum and the periphery are due to intrinsic cellular variation; some mice were 
born with greater phagocytic capacity. While this argument is difficult to refute in its 
entirety, genetics is not suspected to have a significant role in our model. This is because 
our model of 50 percent mortality has been reproduced in inbred mouse strains such as 
BALB\c [75]. Furthermore, while ICR mice are heterogeneous, they are not wild mice 
and are inbred by comparison. 
 
It has been previously shown that the degree of receptor cross-linking can influence 
cellular responses such as calcium flux, degranulation, ROS, or switching from a pro-
inflammatory to anti-inflammatory phenotype [123-125]. Here we have shown an 
increased density of markers for activation (CD11b, CD16). It may be that the increased 
density of receptors (and likely others not measured here) results in increased signaling 
for a given concentration of stimulus. It has been previously shown that Die-P mice have 
increased circulating cytokines, chemokines [22] and mitochondrial DAMPs (MTDs) 
(unpublished data). This could result in neutrophil degranulation [126] or an ROS burst 
prior to their arrival in the peritoneum. This may in part explain the switch from hyper-
reactive BM phagocytes, to hypo-reactive peripheral phagocytes in Die-P mice, despite 
increased complement receptor and FcR expression. In further support of this is the 
increased expression of CD32 on Die-P peripheral phagocytes. CD32, unlike other FcRs, 
has an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) intracellular domain 
rather than an Immunoreceptor Tyrosine-based Activating Motif (ITAM). This results in 
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suppression of inflammatory signaling, the importance of which is exemplified by the 
development of autoimmunity in its absence [127] or the suppression of autoimmunity 
via its engagement by Intravenous Immunoglobulin (IVIG) [128]. It will be important to 
determine whether the increased expression of FcR expression is correlated with or 
causing of the systemic immune suppression following CLP, as they represent attractive 
targets for immune modulation. 
 
Further support of the suppressed phenotype of phagocytes in sepsis was recently 
provided by a study using adenosine receptor antagonists.  Adenosine accumulates in 
hypoxic and inflamed tissues where it suppresses the inflammatory activity of phagocytes 
[129]. Belikoff et al showed that blocking adenosine receptor 2b of Die-P mice improved 
survival, and this benefit was at least in part due to increasing the phagocytic activity of 
macrophages [77]. 
 
Immunosuppression is increasingly seen as detrimental to the host during sepsis [130]. 
Although there is a negligible inflammatory signature during the chronic phase of sepsis, 
there is a surge in inflammatory mediators just prior to mortality [131] that is similar to 
the acute phase surge, albeit of less amplitude. Although too much inflammation is 
implicated in a variety of diseases, for sepsis, it may be that we need to release the 
brakes.  
 
  
67
4 CHAPTER FOUR: THE EFFECTS OF THE SEPTIC INFLAMMATORY 
MILIEU ON PHAGOCYTIC FUNCTION  
Introduction 
Sepsis is a systemic disease that is propagated by immune dysregulation that stems from 
massive trauma and/or infection. In the prototypical regulated immune response, a 
traumatic or infectious insult triggers a pro-inflammatory response consisting of 
biochemical mediators that primes the immune system for action. Once initiated, the pro-
inflammatory drive is thought to self-amplify in a feed-forward positive feedback loop 
When the pro-inflammatory response is of sufficient magnitude, a compensatory anti-
inflammatory response (CAR) is triggered that serves to restrain inflammation and 
prevent excessive bystander damage to the host [24, 25]. However, there is evidence that 
this system of checks and balances may itself initiate the immune dysregulation prevalent 
in sepsis. 
 
Unlike the wave-like transition between pro-inflammatory and anti-inflammatory states 
in classical immune responses, the enormous insult that precedes sepsis produces a 
simultaneous surge in pro and anti-inflammatory mediators that are of similar magnitude 
[132]. It is thought that this produces a state of immunosuppression as evidenced by 
clinical studies documenting viral reactivation [133, 134], opportunistic infections,  and 
global leukocyte suppression [130].  
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Previously it has been shown that Die-P mice produce a larger surge in pro and anti-
inflammatory mediators as compared to Live-P. This increased surge is evident within 
6hr post-CLP in the plasma, and by 24hr in the peritoneum [22]. Similarly, Die-P mice 
show suppressed phagocytic function within 6hr and this suppression extends beyond the 
peritoneum and into the peripheral blood (chapters 2-3). This study sought to determine if 
the inflammatory milieu, produced by Die-P mice within the peritoneum or released 
systemically into the blood, would suppress phagocytic function of naïve cells, relative to 
Live-P. 
 
Methods 
Animals 
Female ICR (CD-1) mice (Harlan-Sprague Dawley, Inc., South Easton, MA) between 24-
28 grams were used for all studies. Mice were received and allowed to acclimate to our 
housing room for at least 96 hours prior to surgery. Mice were kept in a temperature and 
humidity controlled room with a diurnal cycle of 12 hours light, 12 hours dark. Mice 
were given food and water ad libitum for the entire duration of the experiment. The 
experiments were approved by the Boston University Animal Care and Use Committee. 
 
Sepsis Model 
Cecal ligation and puncture was performed as first described [29] with minor 
modifications [41]. Mice were first anesthetized in an induction chamber with 5% 
isofluorane, followed by 3% for maintenance during surgery. A midline incision was 
performed through the skin and then the linea alba. The cecum was exteriorized and 
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ligated below the illeocecal valve with 4-0 silk. Approximately two-thirds the length of 
the cecum from the distal tip was ligated, then double punctured longitudinally with a 16 
gauge needle. A small amount of cecal contents was squeezed out to ensure patency, then 
the cecum was returned to its original position. The abdomen was closed with 4-0 silk 
sutures, and the skin closed with wound glue (Nexaband- Veterinary Products 
Laboratories, Phoenix, Az). Mice were resuscitated with 1mL warm saline (37°) with 
buprenorphine (0.05mg/kg) for pain management (1 injection every 12hours for the first 
two days post-CLP). Antibiotic treatment with 25mg/kg Imipenem was administered 2 
hours post-CLP, and then once every 12 hours for the first 5 days. Mice sacrificed at 6 
hours received one dose of drugs, while mice sacrificed at 24 hours received 3 doses.  
 
Sampling 
Blood sampling was performed at 6 or 24 hours, depending on when the animal was 
sacrificed. 20uL of blood was collected during exsanguination via the retro-orbital 
venous plexus and diluted 1/10 in PBS containing 3.38mM EDTA tripotassium salt, and 
immediately placed on ice. The remainder of the exsanguination volume was collected 
into 100uL Heparin (1000U/mL). Blood was centrifuged for 5 min at 1000 X g at 4°C, 
and the plasma was collected and frozen at -20°C until subsequent analysis for IL-6 to 
determine if the mice were predicted to live or die. The peritoneal cavity was then 
lavaged with 1mL warm Hanks’ Balanced Salt Solution (HBSS, Mediatech Inc., 
Herndon, VA) containing 10U/mL Heparin, followed by centrifugation and storage of the 
supernatant at -20°C. 
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Naïve cells: Bone Marrow cells were flushed from the two hind tibias and femurs with 
cold HBSS + heparin using a 25 gauge needle. Cells were centrifuged, the pellet lysed 
with 1mL 0.2% hypotonic saline for 40 seconds, then restored to isotonicity with 1.6% 
hypertonic saline. Cells were layered onto a discontinuous percoll gradient of 40, 50, and 
62.5% percoll, and centrifuged at 550 X g for 30min at 4°C.  All but the pellet was 
aspirated, and the cell pellet (containing the naïve PMNs) was washed once in PBS with 
0.5% BSA. Resident Peritoneal cells (primarily B1 B-cells and macrophages [85, 86, 
135]) were isolated from the same naïve mouse via peritoneal lavage with warm HBSS 
containing 0.5mM EDTA. The lavage fluid was immediately mixed with cold HBSS w/ 
Ca2+/Mg2+ to prevent intracellular depletion of Ca2+/Mg2+. Cells were washed and then 
resuspended in HBSS w/ Ca2+/Mg2+ 1%BSA at high concentration (15*106/mL<) to 
minimize subsequent dilution of peritoneal fluid or plasma. Cells were diluted to final 
concentration of 4*106/mL (~70% PMN, 30% resident peritoneal cells.) Cells were then 
incubated at 37° For 45 minutes, followed by incubation with bacteria for 30 minutes. 
 
3X-Labeled Bacteria Preparation 
Labeling was performed as previously published[81]. Briefly 2*1010/mL of heat-killed 
(80°C 1hr) HB101 E.coli (same strain used for bacterial killing assay) were sequentially 
labeled with 50uM DCF-SE, 50uM pHrodo-SE, and 159uM Alexafluor-350-SE (Life 
Technologies). Labeling was performed in PBS pH 9.0, degassed and purged with N2 to 
minimize auto oxidation of DCF. Bacteria were washed 3X with PBS pH 8.0, and 
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resuspended in PBS pH7.4 (N2) and stored in glass vials flushed with N2. Bacteria 
(~1.5*1010/mL) were opsonized with 1/10th volume of normal mouse plasma 
(heparinized) and anti-E.coli antibodies (50ug/mL) (Life Technologies). 
 
Phagocytosis Assay 
Cells were diluted to final concentration of 4*106/mL (~70% PMN, 30% resident 
peritoneal cells.) with peritoneal fluid, plasma, or HBSS w/ Ca2+/Mg2+ 1%BSA, and 
placed into a polypropylene cryovial (final volume = 0.25mL).  Tubes were transferred to 
a 37°C water bath, placed on heated stir plate, and agitated at lowest speed for 45minutes 
with 7x2mm micro stir bars. After the 45minute incubation, a saturating dose of 3x-
labeled bacteria were added to each tube. Following incubation, all cells were kept on ice 
until data acquisition with a flow cytometer. No wash steps were performed. 
 
Flow Cytometry 
All data was acquired on an LSRII (Bd Biosciences). 
Doublet discrimination was performed by Fsc-A vs Fsc-H. BD compensation beads (BD 
biosciences) were used for compensation. Additionally, Sytox Blue and R-123 were used 
to stain cells and compared to unstained cells for compensation against those parameters.  
3x Labeled Bacteria- DCF, pHrodo, and Alexafluor-350 fluorescence was collected by 
(wavelength/band pass) 530/15, 590/10, and 450/50 filters. It was important to use a 
custom 590/10 filter for pHrodo because Trypan Blue auto fluoresces when bound to 
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protein and its emission begins at ~615nm. The stock filter supplied by the core facility 
was a 610/20bp.  
Initial PMT settings were chosen such that the MFI of pHrodo and Alexa-350 had a 1:1 
ratio and were ~100-200MFI. DCF PMT were set between 0-100 (DCF has little 
fluorescence prior to oxidation). Once the bacterial settings were in place, a positive 
control (healthy cells + 3x bacteria) was acquired to ensure all events were on scale.  
Trypan Blue was added to tubes (0.25% Final concentration), incubated on ice for 1 
minute, and then ~30,000 gated events were collected.  
 
Data was analyzed with Flowjo (Treestar Inc.). Non-debris cells were gated on by 
Fsc/Ssc. Doublets were removed by fsc-h vs. fsc-w, with care taken to not remove 
activated cells from analysis. Phagocytosis+ gates were constructed for each sample based 
off an ice control (no phagocytosis occurs.) The MFI of quenched ice control cells was 
subtracted from each channel of the 37°C sample, to account for the minimal contribution 
of autofluorescence (minimal because the PMTs were set low enough to get positive 
single bacterial events to read near zero.) Derived parameters were constructed within 
FLowjo so that the DCF or pHrodo fluorescence for each event was divided by the 
fluorescence of Alexa-350 for that event.  
 
Statistical Analysis 
Statistics were performed using Prism 5 software (Graphpad Software, San Diego, CA). 
For comparison between 2 groups, an unpaired Student t test was used.  
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Results 
To recapitulate the early stages of CLP induced sepsis, naïve peritoneal cells were 
combined with naïve PMNs in a ratio that mimicked the 6hr post-CLP cellular profile of 
the peritoneum. Cells were first incubated with peritoneal fluid from Live-P or Die-P 
mice, or HBSS w/ Ca2+/Mg2+ 1%BSA as a control, in order to program the cells prior to 
incubation with bacteria. Peritoneal fluid harvested from mice at 24hr post-CLP was used 
because the difference between the pro and anti-inflammatory surge of Live-P and Die-P 
mice was not statistically significant at 6hr [22].  
 
Incubation with Die-P peritoneal fluid did not result in a difference in the percentage of 
cells phagocytizing (Figure 4-1 B), although overall phagocytosis was decreased (C). 
This mimics the data shown in chapter 2 (Figure 2-7), where the overall percentage of 
cells phagocytizing was similar, but the amount of bacteria phagocytized (phagocytic 
strength) was decreased in Die-P mice.  Due to the small sample size for control cells 
(n=1), it is not clear from this data whether Live-P peritoneal fluid alters phagocytic 
function relative to cells incubated in HBSS alone. 
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Figure 4-1 Die-P Peritoneal Fluid Decreases Phagocytosis by Naïve PMN. A, Gating 
strategy to identify phagocytizing cells. Cells were incubated on ice with bacteria (left 
panel) to prevent phagocytosis and then used to construct gates to exclude non-
phagocytizing cells when analyzing cells incubated at 37°C (right panel).  B, The 
percentage of cells phagocytizing bacteria. C, the overall amount of internalized bacteria, 
determined by the fluorescent intensity of Alexa-350+ events. N=3/group, with each n 
representing peritoneal fluid from an individual mouse. N=1 for HBSS/BSA control. 
 
Quenching the extracellular fluorescence of attached, but not internalized, bacteria with 
trypan blue, enables changes in phagosomal maturation to be observed. To determine if 
the biochemical mediators of CLP-mice affected intracellular processing of bacteria, 
phagosomal ROS and acidification indices were calculated by normalizing DCF (ROS 
sensitive) and pHrodo (pH sensitive) fluorescence to Alexafluor-350 (pH/ROS 
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insensitive) fluorescence. Similar to what is seen with septic cells (chapter 2), naïve cells 
incubated with Die-P peritoneal fluid demonstrate decreased phagosomal acidification 
and ROS generation (Figure 4-2). This suggests that the pro/anti-inflammatory surge 
within the peritoneal cavity of Die-P mice mediates, in part, the immunosuppression of, 
and the reduced bacterial killing by, peritoneal phagocytes that was evident in septic mice 
(chapter 2). Due to the small sample size for control cells (n=1), it is not clear from this 
data whether Live-P peritoneal fluid alters phagocytic function relative to cells incubated 
in HBSS alone. 
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Figure 4-2: Die-P Peritoneal Fluid Suppresses Phagosomal Maturation of Naïve 
PMN. Phagocytosis+ (Alexa-350+) events were analyzed for Phagosomal ROS (A), and 
Phagosomal Acidification (B) by ratioing DCF or pHrodo fluorescence to Alexafluor-350 
fluorescence, respectively. N=3/group, with each N representing peritoneal fluid from an 
individual mouse. N=1 for HBSS/BSA control. 
 
While the bulk of bacterial killing occurs at the infectious source, phagocytes must first 
navigate to the infection via the circulation. While in transit, the immune cells are primed 
by circulating inflammatory mediators that help to prepare the cells for their encounter 
with pathogen. To determine if the circulating biochemical milieu of Live/Die-P mice 
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differentially primes cells, naïve cells were incubated in plasma collected from Live/Die-
P mice 6hr post-CLP. Incubation with plasma produced startling observations that were 
visually apparent based on flow cytometry light scatter alone. Forward scatter (Fsc) 
provides an indication of a cell’s size while Side Scatter (Ssc) indicates granularity or 
internal complexity. Live-P plasma incubation (Figure 4-3, bottom panels) results in a 
distinct population of increasing Fsc and Ssc that is entirely absent from cells incubated 
with Die-P plasma (top panels). The increasing Fsc/Ssc, and the poorer resolution of the 
Non-Debris cell population (and cytospin, data not shown) suggests that Live-P plasma 
primes PMNs to eject Neutrophil Extracellular Traps (NETs). NETs are strings of DNA 
and histones that ensnare microbes and prevent their dissemination, while also possessing 
bactericidal activity [51].  
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Figure 4-3: Live-P plasma promote putative NET Formation in Naïve PMN. 
Forward Scatter and Side Scatter profiles for cells incubated in Die-P plasma (top row) or 
Live-P plasma (bottom row), and then incubated with 3x-labeled bacteria. Live-P plasma 
promotes formation of debris with increasing forward and side scatter. 
 
Somewhat expectantly, Live-P plasma incubation with naive cells results in significantly 
fewer cells phagocytizing (Figure 4-4 A). However, the cells that do phagocytize 
internalize more bacteria, as compared to Die-P (Figure 4-4 B). This might be expected 
because PMNs are the major cell population and if a subset of them have been induced to 
eject their chromosomes, their phagocytic capacity may be greatly diminished. 
Surprisingly, Die-P plasma results in significantly increased phagosomal ROS (C), 
although phagosomal acidification is not different. Also evident in both peritoneal and 
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plasma fluid data is the decreased phagocytic activity of Live/Die-P relative to incubation 
with naïve plasma. Although a larger sample size is needed for the naïve plasma controls, 
it is not surprising that the surge of pro and anti-inflammatory mediators in Live/Die-P 
mice results in less phagocytic activity as compared to naïve cells. 
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Figure 4-4: Live-P/Die-P Plasma Promote Differential Responses to Bacterial 
Phagocytosis in Naïve Cells. A, the percentage of Alexa-350+ cells relative to an ice 
control. B, the geometric mean fluorescent intensity of Alexa-350 for phagocytizing cells 
(Alexa-350+). C, phagosomal ROS production for phagocytizing cells (DCF ÷ Alexa350 
fluorescence). D, phagosomal acidification for phagocytizing cells (pHrodo ÷ Alexa350 
fluorescence). N=3/group, with each N representing plasma from an individual mouse. 
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Discussion 
 
One of the hallmarks of sepsis is an inflammatory surge in conjunction with or followed 
by a state of immunosuppression. It was previously shown that in animals predicted to 
die from sepsis, there was profound suppression in bactericidal mechanisms by 
phagocytes residing in the peritoneum or traversing the circulatory system (chapters 2-3). 
One concern with those studies is the use of outbred heterogeneous mice, as intrinsic 
variability in phagocytic capacity by individuals may predetermine the mice that will live 
versus die. The most important finding in this study was the recapitulation of phagocytic 
suppression, observed in septic mice, with naïve cells incubated with humoral fluids 
(peritoneum, plasma) and heat-killed bacteria. This suggests that it is humoral elements 
secreted in response to sepsis that largely determine phagocytic activity, and by 
extension, survival. While genetics undoubtedly contribute to the clinical scenario, these 
studies here and previous ones with homogeneous mice [75] help to minimize genetics as 
a confounding factor in a model of 50% mortality. 
 
While the findings of phagocytic and phagosomal suppression in this study were 
somewhat of a surprise, as both Live-P and Die-P mice produce large amount of pro and 
anti-inflammatory mediators, the idea that soluble mediators affect phagosomal 
maturation is not new. Studies with macrophage phagocytosis of mycobacterium have 
shown that the pro-inflammatory cytokines IFNγ and IL-6 augment phagolysosomal 
fusion [136, 137], while the addition of anti-inflammatory IL-10 decreases 
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phagolysosomal fusion [138]. Similarly, IFNγ increases ROS production by macrophages 
[139] while IL-10 depresses neutrophil ROS [140]. However, a more relevant study 
observed that the simultaneous addition of IFNγ and IL-10 to dendritic cells (DC) 
significantly suppressed TNF and IL-12p40 production more so than if given just IFNγ or 
IL-10 alone. More importantly, concomitant administration of IFNγ and IL-10 suppressed 
DC activation of CD4 T-cells [141]. As both pro and anti-inflammatory mediators surge 
in Live/Die-P mice, it may be that the significantly stronger surge in Die-P mice results in 
stronger suppression. 
 
As important as the observation that humoral fluids differentially affect phagocytic 
function, perhaps more important is that 6hr Live-P plasma induces putative NET 
formation while Die-P and naïve plasma do not. While formal determination of NET 
presence has not yet been performed, several findings support that these are NETs: first-
The shift in light scatter showing decreased resolution of the PMN population along with 
increased aggregation of debris and/or bacteria; second-the decreased percentage of cells 
phagocytizing that is presumably due to a portion of the cells that have ejected their 
chromosomes [142]; and third- The decreased ROS burst from Live-P plasma incubated 
cells may reflect their consumption of NOX activity used to generate NETS and their 
release of myeloperoxidase along with the NETS [143]. 
 
The putative NET formation by Live-P incubated cells could further explain why despite 
similar bacterial loads 6hr post-CLP (chapter 2, [22]), Die-P mice fail to contain the 
  
81
infection. NET formation has been shown to trap bacteria and prevent dissemination 
during sepsis [144]. The importance of this was recently shown when following CLP, 
mice that were injected with DNAse showed increased mortality within 24hr, increased 
bacterial dissemination, increased IL-6, and increased neutrophil recruitment [145]. It is 
tempting to speculate that the failure to produce NETs allows greater dissemination of 
bacteria within the peritoneum, leading to increased cellular activation and cytokine 
secretion, thus partially explaining the difference in phagocytic function, inflammatory 
profiles, and survival despite equivalent inoculums. 
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5 CHAPTER FIVE: GENERAL DISCUSSION 
 
Prior to the start of this study, the prevailing wisdom was that sepsis is mediated at first 
by a large pro-inflammatory storm and patients died of hyperinflammation. Those that 
survived the pro-inflammatory drive were then caught in a compensatory anti-
inflammatory response. Patients that succumbed during this phase were considered 
immunosuppressed. Numerous therapies aimed at blunting hyperinflammation in hopes 
of preventing organ failure, failed. There are likely many reasons why these therapies 
failed, and poor study design may be at the forefront [30]. This is likely due to treating 
sepsis as a single static disease defined clinically as SIRS plus infection rather than as a 
dynamic disorder, and therefore a one size fits all approach is unlikely to be efficacious. 
As this study concludes, there are still clinical trials moving forward aimed at blunting 
the immune response and some being recalled due to their increasing mortality [146]. 
However, there is progress towards a more holistic understanding of sepsis within the 
research community, with evidence for enhancing immunity rather than blunting it [101, 
102, 113, 147, 148], and attempts at stratifying patients most at risk for progressing 
beyond SIRS into sepsis [149]. This study supports the path forward and may contribute 
to new approaches to sepsis disease management. 
 
Like other studies, ours shows immune system suppression, but with a substantial novel 
information. In a recent review, Hotchkiss et al. [109] stated that although a SIRS/CARS 
surge is present in sepsis, the initial stages are predominated by hyperinflammation. 
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Previous studies from our lab support this from a cytokine/chemokine standpoint, as the 
total contribution from pro-inflammatory mediators is somewhat greater than anti-
inflammatory mediators [22, 131]. However, this body of work shows that the mice with 
a greater inflammatory surge are still immunosuppressed. Can they be simultaneously 
dying from too much inflammation, and yet, not enough inflammation? Osuchowski et al 
showed that low dose administration of dexamethasone (DEX), an anti-inflammatory 
corticosteroid, to Die-P mice resulted in increased survival [76]. Importantly, this benefit 
was only evident when mice were stratified for treatment, as treating all CLP mice with 
DEX did not decrease mortality. How can restraining inflammation augment the 
inflammatory response?  The answer may reside in the role of PMNs and how they are 
ill-suited for hyperinflammatory conditions 
 
Although PMNs are often regarded primarily as the first responders to an infection and as 
the cells frequently associated with host tissue injury, their role as immuno-regulators is 
gaining more prominence. In cancer, PMNs were shown to suppress CD8-Tcell 
activation via an IL-10 dependent mechanism [150]. In sterile lung inflammation PMNs 
suppressed inflammation via ROS production [151]. LPS stimulation of human whole 
blood results in anti-inflammatory cytokine production by neutrophils [152].  In CLP 
induced sepsis, PMNs have been shown to be significant producers of IL-10 and decrease 
mortality by limiting inflammation [153, 154]. However, neutrophils have also been 
shown to be dispensable during some infections. In their absence, inflammatory 
monocytes pick up the slack and eradicate the infection [155], and this is likely due to 
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alleviating PMN mediated suppression of monocytes via IL-10 [71] . How then may the 
positive contributions of PMNs go awry in CLP-induced sepsis? 
 
Severe trauma such as CLP results in hyperinflammatory conditions due to the 
widespread dissemination of DAMPs from necrotic cecum, and bacterial PAMPs from 
the stool. Although clinically relevant, these conditions may not represent the more 
typical scenarios of localized inflammation that is less severe, and for which neutrophil 
and immunity likely evolved. In such conditions, neutrophils are attracted by chemokines 
produced at the site of infection. As PMNs arrive, they engage the pathogen and are 
induced to quickly release pre-packaged stores of chemokines that call for more PMNs 
[156] in a feed forward manner similar to that depicted in chapter 1 (Figure 1-1). 
Attenuation of inflammation should increase as more PMNs arrive, and this is likely due 
to the suppressive actions of exocytosed PMN granules [157] and ROS [151]. This 
gradual process likely allows for efficient elimination of microbes before suppression 
takes place. However, CLP with its atypical immune signaling load likely triggers 
premature suppression. This is supported by our studies and others. Six hours post-CLP, 
Die-P PMNs generate little ROS via stimulation by opsonized bacteria, and they show 
limited capacity to generate ROS following PMA stimulation (Figure 2-4, Figure 2-5). 
NOX-derived ROS signaling results in the activation of anti-inflammatory Nrf2 [151]. It 
is likely that the events that led to the exhaustion of NOX activity (i.e. phagocytosis, 
extracellular PAMPs, chemotactic agents) produced sufficient ROS to trigger Nrf2. It is 
important to keep in mind that PMN NOX ROS can be released extracellularly, thereby 
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increasing the redox signaling of nearby cells, leading to their own Nrf2 induction. 
Meanwhile, the infection continues to spread and results in further pro-inflammatory 
signaling and as this increases in strength, so does the anti-inflammatory signaling. How 
likely is this scenario in our model of CLP? 
 
Belikoff et al. showed that Die-P could be rescued by releasing the brakes on 
inflammation by blocking adenosine receptor 2B (A2BR). Importantly, it was shown that 
in the absence of A2BR signaling, macrophages demonstrated increased phagocytosis 
and cytokine production following CLP. However, there was no difference observed for 
PMN phagocytosis. It may be that A2BR blockade helped to alleviate some of the PMN-
mediated inhibition of macrophage function that is present following CLP [71]. In further 
support of too much inflammation triggering a suppressive phenotype, Osuchowski et al 
showed that low dose administration of dexamethasone (DEX), an anti-inflammatory 
corticosteroid, to Die-P mice resulted in increased survival [76]. In other studies, DEX 
has been shown to inhibit phagocyte ROS production and increase PMN survival [158-
160]. It may be that DEX improves Die-P survival by preventing newly recruited 
peritoneal PMNs and macs from premature suppression via ROS signaling.  
 
This may in part explain the transition from hyper-reactive BM phagocytes (Figure 3-1) 
to hypo-reactive cells in the periphery and peritoneum of Die-P mice. Their increased 
sensitivity to opsonized bacteria, and by extension, their increased sensitivity to 
circulating PAMPs and DAMPs may trigger premature ROS and degranulation. 
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Premature degranulation could have other effects besides impaired phagocytic activity. 
Die-P BM and peripheral phagocytes have increased surface expression of CD11b. 
Chishti et al reported that sepsis results in increased adhesion of neutrophils to the 
endothelium, owing to increased CD11b expression [161]. Increased activation of 
neutrophils predisposes them to increased degranulation upon pattern recognition 
receptor, i.e. Toll like receptor ligation [162-164], leading to increased vascular injury 
[165] which is prevalent in sepsis [166, 167]. This also fits with unpublished data from 
our lab that shows decreased heart rate and pulse distension in mice that die from CLP. 
This may also fit with our recent study that documented renal injury prior to death from 
CLP [92], as neutrophil degranulation has been shown to be involved in animal models of 
glomerulonephritis [168]. 
 
Acute vs. Chronic Sepsis  
 
Taken together, the aforementioned studies and ours provide a plausible explanation as to 
why mice die from too much inflammation, and yet not enough inflammation. However, 
our studies dealt with acute phase mortality, whereas most clinical mortality occurs 
during the chronic phase. This is in part due to the advances in clinical care that has led to 
patients surviving the hyperinflammatory phase and entering a protracted state of 
immunosuppression [109]. However, our studies show that mice are indeed 
immunosuppressed during this hyperinflammatory phase. Are patients similarly 
immunosuppressed during the acute phase, and thanks to source control and early goal 
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directed therapy (EGDT), they stay alive to be immunosuppressed a little longer? Animal 
studies seem to suggest so.  
 
A previous study by our lab showed that cecal resection, a form of source control, at 8hr 
post-CLP saved all Die-P mice that were followed out to 21 days post-CLP [75]. A 
similar study where resection was performed on mice still alive by day 4 showed that 
some mice succumbed to infection following resection, suggesting a state of 
immunosuppression as the infectious source was removed [70]. It may be that Live-P and 
Die-P differentially reprogram global immunity for immune-vigilance or suppression 
following CLP. In further support of this is a study by Delano et al that performed a mild 
form of CLP that resulted in approximately 10% mortality with the majority of deaths 
occurring within 3 days of CLP. Survivors can loosely be considered Live-P equivalents. 
When these survivors were challenged with pneumonia 7 days later, they showed similar 
mortality to sham mice [114]. In the same vein, Pastille et al showed that CLP resulted in 
sustained immunosuppression of dendritic cells (DC), and that this was due to changes in 
the DC progenitors in the bone marrow [169]. Would Die-P mice similarly reprogram 
their marrow for sustained immunosuppression if they were rescued from their acute 
fate? These studies need to be performed, but there is additional reason to believe 
sustained immunosuppression would develop. Circulating factors are known to influence 
myelopoeisis and enhance neutrophil function [170]. We showed in chapter 4 that Die-P 
fluids result in phagocytic suppression, and bone marrow alterations became evident by 
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24hr post-CLP. It may be that these alterations would produce a sustained state of 
immunosuppression, as is the case for humans. 
 
Although our studies provide strong evidence for phagocyte suppression preceding 
mortality, they do not suggest how this comes to be. Given that mice receive the same 
inoculum, why do some mice go on to die while others do not? Although mice may 
receive similar cecal inoculums, their cecal contents may differ in the presence and/or 
prevalence of certain bacteria. Silva et al showed that a particular strain of E. coli present 
in mice impaired macrophage phagocytosis during CLP and that this was due to FcR:E. 
coli interactions [63]. Similarly Bacteroides fragilis  and Faecalibacterium prausnitzii 
are commensal bacteria that modulate immune responses by encouraging tolerance, as 
evidenced by the development of intestinal inflammation without them [171, 172]. 
Perhaps an element of chance exists in which Die-P immune cells encounter tolerance-
promoting commensals first, while Live-P mice have the good fortune of recognizing 
non-tolerance inducing commensals first. In this situation, inflammatory processes would 
be suppressed in Die-P, allowing increased bacterial dissemination before a more robust 
inflammatory response could begin. 
 
Another possibility, and one with more direct evidence to support it, is that Die-P mice 
have circulating inhibitory IgG that is present prior to CLP. Moitra et al. showed that 
mortality could be predicted prior to performing CLP [173]. This was performed by 
collecting plasma samples from mice several days prior to CLP, and using them in an ex-
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vivo bacterial killing assay. Opsonization of bacteria with plasma samples from mice that 
would go on to die from subsequent CLP, resulted in less macrophage mediated bacterial 
killing, as compared to mice that survived CLP. Preliminary studies suggest that the 
plasma factor responsible is an inhibitory IgG. Similar to tolerance-inducing commensals, 
iIgG may work to suppress unwanted inflammation against the healthy microbiota. In the 
context of CLP, this would result in non-survivors beginning their response from an 
immunosuppressed state, thereby facilitating bacterial dissemination and the subsequent 
SIRS/CARS surge. As many patients who become septic are already immunosuppressed, 
it is likely that our acute phase model recapitulates human sepsis more than we 
appreciate. 
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